1
|
Gutiérrez J, González-Acuña D, Fuentes-Castillo D, Fierro K, Hernández C, Zapata L, Verdugo C. Antibiotic resistance in wildlife from Antarctic Peninsula. Sci Total Environ 2024; 916:170340. [PMID: 38278249 DOI: 10.1016/j.scitotenv.2024.170340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 01/19/2024] [Accepted: 01/19/2024] [Indexed: 01/28/2024]
Abstract
Although considered one of the most pristine ecosystems, Antarctica has been largely influenced by human activities during the last 50 years, affecting its unique biodiversity. One of the major global threats to health is the emergence of antibiotic-resistant bacteria that may be actively transferred to wildlife. We cultured and tested for antibiotic resistance in 137 cloacal and fresh fecal samples of several avian and marine mammal species from the Antarctic Peninsula, the most impacted area in Antarctica. Alarmingly, 80 % of the isolates showed antibiotic resistance, either phenotypically or genotypically. Most of the resistant bacteria, such as Enterobacteriaceae and Enterococcus species, are part of local gastrointestinal microbiota. Penguins and pinnipeds harbored a great diversity of antibiotic resistance and must be eligible as sentinels for future studies. These results show that antibiotic resistance has rapidly transferred to bacteria in Antarctic wildlife, which is a global matter of concern.
Collapse
Affiliation(s)
- Josefina Gutiérrez
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile; Center of Surveillance and Evolution of Infectious Diseases, Universidad Austral de Chile, Valdivia, Chile
| | | | - Danny Fuentes-Castillo
- Departamento de Patología y Medicina Preventiva, Universidad de Concepción, Chillán, Chile
| | - Karina Fierro
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile
| | - Carlos Hernández
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile
| | - Loreto Zapata
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile
| | - Claudio Verdugo
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile; Center of Surveillance and Evolution of Infectious Diseases, Universidad Austral de Chile, Valdivia, Chile.
| |
Collapse
|
2
|
Chenaud B, Hernández C, Delgard A, Chaubet C. Influence of coaxial cable resistance on impedance measurements at low frequency and guidelines for phase determination of ac electrical signals. Rev Sci Instrum 2023; 94:115112. [PMID: 38019111 DOI: 10.1063/5.0172200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 11/08/2023] [Indexed: 11/30/2023]
Abstract
We present an experimental study on ac measurements at low frequencies (below 1 MHz) when the coaxial cables used for the measurement are resistive, as in cryogenic conditions. More precisely, we are interested in admittance or impedance measurements and the accurate determination of the phase. Our experiments were completed using an auto-balancing bridge impedance analyzer and various standard coaxial cables, as well as their serial combinations. We characterize the experimental setup, and then, we analyze and measure the phase shift introduced in impedance measurements by lead resistance. Using basic equations for electrical signal propagation in coaxial cables, we calculate phase shift in the whole frequency range and explain our data in the low frequency limit of our model. We propose a quantitative criterion to determine whether the experimental context is appropriate. If not, we show that by using an original calibration procedure, the imaginary part can be accurately recovered, avoiding artifacts. The calibration procedure can be applied to any ac voltage or current measurement, whatever the detection technique is, with known accuracy.
Collapse
Affiliation(s)
- Boris Chenaud
- L2C, Univ. Montpellier, CNRS, Montpellier 34095, France
| | - Carlos Hernández
- Departamento de Física, Universidad Militar Nueva Granada, Carrera 11 # 101-80, Bogotá DC, Colombia
| | | | | |
Collapse
|
3
|
Gaya JM, Territo A, Woldu S, Schwartzmann I, Verri P, González-Pérez L, Cózar JM, Miñana B, Medina RA, de la Rosa-Kehrmann F, Lozano-Palacio F, Ribal MJ, Hernández C, Castiñeiras JJ, Requena MJ, Moreno J, Caraballido JA, Baena V, Breda A, Palou Redorta J. Incidental diagnosis of bladder cancer in a national observational study in spain. Actas Urol Esp 2023; 47:296-302. [PMID: 36443223 DOI: 10.1016/j.acuroe.2022.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 09/13/2022] [Accepted: 09/14/2022] [Indexed: 06/05/2023]
Abstract
INTRODUCTION Bladder cancer (BC) is a common malignancy in Spain. The aims of this study were: to identify the proportion of patients diagnosed with BC incidentally or after symptomatic presentation in a contemporary period in Spain; to compare demographic, clinical, and pathologic characteristics between these groups. METHODS This was a retrospective analysis of a multi-centre observational study of 26 hospitals in the Spanish National Health System of all BCs newly diagnosed in 2011. The study represented 21.5% of the Spanish population and hospitals were selected in proportion to Spain's regions to ensure a representative sample. Patients were categorized by whether the cancer was diagnosed incidentally or after symptomatic presentation and baseline demographic, pathologic, and clinical characteristics were analyzed. RESULTS 2472 were newly diagnosed with BC at the 26 participating Spanish hospitals with 308 (12.5%) of cases diagnosed incidentally and 2164 (87.5%) diagnosed after symptomatic presentation. No differences were observed between patients diagnosed incidentally vs. symptomatically in terms of demographics or measured co-morbidities. Compared to symptomatically diagnosed bladder tumours, those diagnosed incidentally were more likely to have a papillary appearance, to be significantly smaller, and less likely to have positive/suspicious cytology. Additionally, incidentally diagnosed bladder tumours were less likely to be muscle-invasive (11.7% vs. 25.0%, p < 0.01) nor aggressive at pathology, with 33.6% Grade 3 compared to 50.1%, (p < 0.01). CONCLUSIONS We identified a significant percentage (12.5%) of new bladder cancer diagnosis made incidentally in a representative sample of the Spanish population. These tumours exhibited less aggressive pathologic characteristics than their symptomatic counterparts.
Collapse
Affiliation(s)
- J M Gaya
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain.
| | - A Territo
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain
| | - S Woldu
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain
| | - I Schwartzmann
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain
| | - Paolo Verri
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain
| | | | - Jose M Cózar
- Departamento de Urología, Hospital Virgen de las Nieves, Granada, Spain
| | | | - Rafael A Medina
- Departamento de Urología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | | | | | - Maria J Ribal
- Departamento de Urología, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Carlos Hernández
- Departamento de Urología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Jesús J Castiñeiras
- Departamento de Urología, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - María J Requena
- Departamento de Urología, Hospital Reina Sofía, Córdoba, Spain
| | - Jesús Moreno
- Departamento de Urología, Hospital Clínico San Carlos, Madrid, Spain
| | | | - Victor Baena
- Departamento de Urología, Hospital Carlos Haya, Málaga, Spain
| | - Alberto Breda
- Departamento de Urología, Fundació Puigvert, Barcelona, Spain
| | | |
Collapse
|
4
|
Ortiz-Zuñiga AM, Rojano Toimil A, Rahnama K, Lainez E, Raguer N, Simó-Servat O, Hernández C, Simó R, Ciudin A. Retinal sensitivity and gaze fixation evaluated by microperimetry in subjects with type 2 diabetes: two independent parameters that explore different neuronal circuits. J Endocrinol Invest 2023:10.1007/s40618-023-02046-y. [PMID: 36870015 PMCID: PMC10371889 DOI: 10.1007/s40618-023-02046-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Accepted: 02/19/2023] [Indexed: 03/05/2023]
Abstract
BACKGROUND AND AIMS Retinal sensitivity (RS) and gaze fixation (GF) assessed by retinal microperimetry are useful and complementary tools for identifying mild cognitive impairment (MCI) in patients with type 2 diabetes (T2D). The hypothesis is that RS and GF examine different neural circuits: RS depends only on the visual pathway while GF reflects white matter complex connectivity networks. The aim of the study is to shed light to this issue by examining the relationship of these two parameters with visual evoked potentials (VEP), the current gold standard to examine the visual pathway. MATERIALS AND METHODS Consecutive T2D patients > 65 years were recruited from the outpatient clinic. Retinal microperimetry (MAIA 3rd generation) and visual evoked potentials (VEP) (Nicolet Viking ED). RS (dB), GF (BCEA63%, BCEA95%) (MAIA) and VEP (Latency P100ms, Amplitude75-100 uV) were analyzed. RESULTS Thirty three patients (45% women, 72.1 ± 4.6 years) were included. VEP parameters significantly correlated with RS but not with GF. CONCLUSIONS These results confirm that RS but not GF depends on the visual pathway, reinforcing the concept that they are complementary diagnostic tools. Used together can further increase the value of microperimetry as screening test for identifying T2D population with cognitive impairment.
Collapse
Affiliation(s)
- A M Ortiz-Zuñiga
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
- Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Pg Vall Hebron 119-129, 08035, Barcelona, Spain
| | - A Rojano Toimil
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
| | - K Rahnama
- Department of Clinical Neurophysiology, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
| | - E Lainez
- Department of Clinical Neurophysiology, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
| | - N Raguer
- Department of Clinical Neurophysiology, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
| | - O Simó-Servat
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
- Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Pg Vall Hebron 119-129, 08035, Barcelona, Spain
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, C/Monforte de Lemos 3-5.Pabellón 11, 28029, Madrid, Spain
| | - C Hernández
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain
- Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Pg Vall Hebron 119-129, 08035, Barcelona, Spain
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, C/Monforte de Lemos 3-5.Pabellón 11, 28029, Madrid, Spain
| | - R Simó
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain.
- Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Pg Vall Hebron 119-129, 08035, Barcelona, Spain.
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, C/Monforte de Lemos 3-5.Pabellón 11, 28029, Madrid, Spain.
| | - A Ciudin
- Department of Endocrinology and Nutrition, Hospital Universitari Vall Hebron, Pg Vall Hebron 119-129, 08035, Barcelona, Spain.
- Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Pg Vall Hebron 119-129, 08035, Barcelona, Spain.
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, C/Monforte de Lemos 3-5.Pabellón 11, 28029, Madrid, Spain.
| |
Collapse
|
5
|
Iturriaga M, Marichal E, Longueira AR, Hernández C, Mancina CA. New record size, increased distribution range, and threat category reassessment proposal for Tropidophis morenoi (Squamata: Tropidophiidae). Phyllomedusa 2022. [DOI: 10.11606/issn.2316-9079.v21i2p235-242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
6
|
Pérez-Bernal M, Hernández C, Ibargollín R, Martínez M, Soria M, Delgado M, Valdivia O, Dorta D, Domínguez A, Pérez E, Cabrera Y. SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala. Infect Med (Beijing) 2022; 1:253-261. [PMID: 38013910 PMCID: PMC9671870 DOI: 10.1016/j.imj.2022.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 11/07/2022] [Accepted: 11/14/2022] [Indexed: 11/19/2022]
Abstract
Background COVID-19 vaccines that trigger a strong secretory antibody response in breast milk may achieve effective passive protection of vulnerable newborns and breastfed infants of immunized mothers. The aim of this work was to investigate the presence of SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk, 5 and 9 weeks after vaccination with 3 doses of the protein subunit vaccine Abdala, compared to those found in breast milk from COVID-19-recovered women, collected at least 40 days after the infection. Methods SARS-CoV-2 spike RBD-specific IgA and IgG antibodies were semi-quantified by indirect ELISA, using a homemade standard generated by pooling twenty breast milk samples with high absorbance values according to preliminary data. The validity of the standard curves was proved following the European Medicines Agency Guideline. Two breast milk samples from 2 unvaccinated women who had not been infected with COVID-19 were included as negative controls. Potentially neutralizing antibodies was assessed by a SARS-CoV-2 surrogate virus neutralization test. Results High levels of anti-RBD IgA antibodies were detected in breast milk samples 9 weeks after vaccination and anti-RBD IgG antibodies rise from the fifth to the ninth week. In the post-COVID-19 time that was evaluated, the IgG-type response was notably higher compared to both post-vaccination periods. Neutralizing antibody titers were similar in breast milk from vaccinated and COVID-19 recovered women. Conclusions This is the first report about the immune response in breast milk after the administration of a COVID-19 protein subunit vaccine, which could provide analogous protection to that conferred by SARS-CoV-2 infection. This implies a potential passive immunity that breastfed infants receive from their mothers vaccinated with Abdala.
Collapse
Affiliation(s)
- Maylin Pérez-Bernal
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Carlos Hernández
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Rafael Ibargollín
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Midalis Martínez
- Neonatology Service, General Hospital "Camilo Cienfuegos", 128 Bartolome Maso, Sancti Spiritus, Cuba
| | - Migdiala Soria
- Neonatology Service, General Hospital "Camilo Cienfuegos", 128 Bartolome Maso, Sancti Spiritus, Cuba
| | - Magali Delgado
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Onel Valdivia
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Dayamí Dorta
- Production Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Andy Domínguez
- Production Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Enrique Pérez
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| | - Yeosvany Cabrera
- Research & Development Department, Center for Genetic Engineering and Biotechnology, Circunvalante Norte, Olivos III, Sancti Spiritus, Cuba
| |
Collapse
|
7
|
Viñas MJ, Galiotto-Barba F, Cortez-Lede MG, Rodríguez-González MÁ, Moral I, Delso E, González-Meli B, Lobo F, López-Cedrún JL, Neagu D, Garatea J, Garatea A, Berenguer B, Lorca-García C, Delgado MD, Martí E, Gutiérrez JM, Hernández C, Murillo-González J, Martínez-Álvarez C, Martínez-Sanz E. Craniofacial and three-dimensional palatal analysis in cleft lip and palate patients treated in Spain. Sci Rep 2022; 12:18837. [PMID: 36336749 PMCID: PMC9637697 DOI: 10.1038/s41598-022-23584-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Accepted: 11/02/2022] [Indexed: 11/08/2022] Open
Abstract
Growth alterations have been described in patients operated on for oral clefts. The purpose of this work was to analyze the craniofacial and palate morphology and dimensions of young adults operated on for oral clefts in early childhood in Spain. Eighty-three patients from eight different hospitals were divided into four groups based on their type of cleft: cleft lip (CL, n = 6), unilateral cleft lip and palate (UCLP, n = 37), bilateral cleft lip and palate (BCLP, n = 16), and cleft palate only (CPO, n = 24). A control group was formed of 71 individuals. Three-dimensional (3D) digital models were obtained from all groups with an intraoral scanner, together with cephalometries and frontal, lateral, and submental facial photographs. Measurements were obtained and analyzed statistically. Our results showed craniofacial alterations in the BCLP, UCLP, and CPO groups with an influence on the palate, maxilla, and mandible and a direct impact on facial appearance. This effect was more severe in the BCLP group. Measurements in the CL group were similar to those in the control group. Cleft characteristics and cleft type seem to be the main determining factors of long-term craniofacial growth alterations in these patients. Prospective research is needed to clearly delineate the effects of different treatments on the craniofacial appearance of adult cleft patients.
Collapse
Affiliation(s)
- María José Viñas
- grid.4795.f0000 0001 2157 7667Facultad de Odontología, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Francesca Galiotto-Barba
- grid.4795.f0000 0001 2157 7667Facultad de Odontología, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - María Gabriela Cortez-Lede
- grid.419058.10000 0000 8745 438XHospital Clínico Universitario Virgen de la Arrixaca, Servicio Murciano de Salud, 30120 Murcia, Spain
| | - María Ángeles Rodríguez-González
- grid.419058.10000 0000 8745 438XHospital Clínico Universitario Virgen de la Arrixaca, Servicio Murciano de Salud, 30120 Murcia, Spain
| | - Ignacio Moral
- grid.438293.70000 0001 1503 7816Hospital Universitario Miguel Servet, Servicio Aragonés de Salud, 50009 Zaragoza, Spain
| | - Elena Delso
- grid.438293.70000 0001 1503 7816Hospital Universitario Miguel Servet, Servicio Aragonés de Salud, 50009 Zaragoza, Spain
| | - Beatriz González-Meli
- grid.410361.10000 0004 0407 4306Hospital Universitario Infantil Niño Jesús, Servicio Madrileño de Salud, 28009 Madrid, Spain
| | - Fernando Lobo
- grid.410361.10000 0004 0407 4306Hospital Universitario Infantil Niño Jesús, Servicio Madrileño de Salud, 28009 Madrid, Spain
| | - José Luis López-Cedrún
- grid.420359.90000 0000 9403 4738Complejo Hospitalario Universitario A Coruña, Servizo Galego de Saúde, 15006 A Coruña, Spain
| | - David Neagu
- grid.420359.90000 0000 9403 4738Complejo Hospitalario Universitario A Coruña, Servizo Galego de Saúde, 15006 A Coruña, Spain
| | - Joaquín Garatea
- grid.419060.a0000 0004 0501 3644Complejo Hospitalario de Navarra, Servicio Navarro de Salud, 31008 Pamplona, Spain
| | - Amaia Garatea
- grid.419060.a0000 0004 0501 3644Complejo Hospitalario de Navarra, Servicio Navarro de Salud, 31008 Pamplona, Spain
| | - Beatriz Berenguer
- grid.410361.10000 0004 0407 4306Hospital General Universitario Gregorio Marañón, Servicio Madrileño de Salud, 28009 Madrid, Spain
| | - Concepción Lorca-García
- grid.410361.10000 0004 0407 4306Hospital General Universitario Gregorio Marañón, Servicio Madrileño de Salud, 28009 Madrid, Spain
| | - María Dolores Delgado
- grid.410361.10000 0004 0407 4306Hospital Universitario 12 de Octubre, Servicio Madrileño de Salud, 28041 Madrid, Spain
| | - Eunate Martí
- grid.410361.10000 0004 0407 4306Hospital Universitario 12 de Octubre, Servicio Madrileño de Salud, 28041 Madrid, Spain
| | - José Manuel Gutiérrez
- grid.459669.10000 0004 1771 1036Hospital Universitario de Burgos, Sanidad de Castilla y León, 09006 Burgos, Spain
| | - Carlos Hernández
- grid.459669.10000 0004 1771 1036Hospital Universitario de Burgos, Sanidad de Castilla y León, 09006 Burgos, Spain
| | - Jorge Murillo-González
- grid.4795.f0000 0001 2157 7667Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Concepción Martínez-Álvarez
- grid.4795.f0000 0001 2157 7667Facultad de Odontología, Universidad Complutense de Madrid, 28040 Madrid, Spain ,grid.4795.f0000 0001 2157 7667Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Elena Martínez-Sanz
- grid.4795.f0000 0001 2157 7667Facultad de Odontología, Universidad Complutense de Madrid, 28040 Madrid, Spain ,grid.4795.f0000 0001 2157 7667Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain
| |
Collapse
|
8
|
Gaya J, Territo A, Woldu S, Schwartzmann I, Verri P, González-Pérez L, Cózar J, Miñana B, Medina R, de la Rosa-Kehrmann F, Lozano-Palacio F, Ribal M, Hernández C, Castiñeiras J, Requena M, Moreno J, Caraballido J, Baena V, Breda A, Palou Redorta J. Diagnóstico incidental del cáncer de vejiga en España. Estudio observacional a nivel nacional. Actas Urol Esp 2022. [DOI: 10.1016/j.acuro.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
9
|
Hernández C, Yeoh W, Baier JA, Zhang H, Suazo L, Koenig S, Salzman O. Simple and Efficient Bi-Objective Search Algorithms via Fast Dominance Checks. ARTIF INTELL 2022. [DOI: 10.1016/j.artint.2022.103807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
10
|
Cuñat T, Martínez-Pastor JC, Dürsteler C, Hernández C, Sala-Blanch X. Perioperative medicine role in painful knee prosthesis prevention. Rev Esp Anestesiol Reanim (Engl Ed) 2022; 69:411-420. [PMID: 35869007 DOI: 10.1016/j.redare.2022.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 03/25/2021] [Indexed: 06/15/2023]
Abstract
Total knee arthroplasty is one of the most frequently performed orthopaedic surgeries. However, up to 20% of patients develop persistent postoperative pain. Persistent postoperative pain may be an extension of acute postoperative pain, but can also occur after more than 3 months without symptoms. Risk factors associated with persistent postoperative pain after arthroplasty have now been characterised within the patient's perioperative context (preoperative, intraoperative and postoperative), and can be grouped under genetic, demographic, clinical, surgical, analgesic, inflammatory and psychological factors. Identification and prevention of persistent postoperative pain through a multimodal and biopsychosocial approach is essential in the context of perioperative medicine, and has been shown to prevent or ameliorate postoperative pain.
Collapse
Affiliation(s)
- T Cuñat
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, Spain.
| | - J C Martínez-Pastor
- Servicio de Traumatología y Cirugía Ortopédica, Hospital Clinic de Barcelona, Barcelona, Spain
| | - C Dürsteler
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, Spain
| | - C Hernández
- Servicio de Anestesiología y Reanimación, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Barcelona, Spain
| | - X Sala-Blanch
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, Spain
| |
Collapse
|
11
|
Horodyski L, Gonzalez J, Tabbara MM, Gaynor JJ, Rodriguez-Cabero M, Herranz-Amo F, Hernández C, Shah R, Ciancio G. En Bloc Resection of Right Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus Without Caval Reconstruction: Is It Safe to Divide the Left Renal Vein? Front Oncol 2022; 12:877310. [PMID: 35847837 PMCID: PMC9280635 DOI: 10.3389/fonc.2022.877310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Accepted: 05/19/2022] [Indexed: 11/26/2022] Open
Abstract
Introduction It has been suggested that inferior vena cava (IVC) reconstruction following resection of retroperitoneal tumors with IVC tumor thrombus (TT) is not required when adequate collateral circulation is present. There are no reports evaluating mid-term effects on renal function in these patients. The purpose of this study was to assess renal function after en bloc resection of right renal cell carcinoma (RCC) with obstructing IVC TT and the possible risks that may arise after left renal vein division. Materials and Methods A bi-institutional retrospective review was performed over a 15-year period, assessing patients with right RCC and obstructing level II–IV TT. All patients underwent extensive evaluation and cardiology clearance, and informed consent was obtained for right radical nephrectomy and thrombectomy with or without IVC reconstruction with possible cardiopulmonary bypass (CPB). Patient demographics, tumor characteristics, intraoperative factors, complications, length of stay, and patient survival were evaluated. Preoperative creatinine was recorded, as was creatinine on the day of discharge and at 6 and 12 months postoperatively. Results Twenty-two patients were included in the study. Median age at surgery was 62.5 (range: 45–79) years, and 19 (86%) of the patients were men. One patient (5%) had a level II thrombus, 14 patients (64%) had a level III thrombus (IIIa, n = 3; IIIb, n = 6; IIIc, n = 3; IIId, n = 2), and seven patients (32%) had a level IV thrombus. Intraoperatively, median estimated blood loss was 1.35 (range: 0.2–25) L. The median length of hospital stay was 11 (range: 5–50) days. Median preoperative creatinine was 1.20 (range: 0.40–2.70) mg/dl, and postoperatively, median creatinine was 1.3 (range: 0.86–2.20) mg/dl. Median creatinine levels at 6 months and 12 months postoperatively were 1.10 (range: 0.5–1.8) mg/dl and 1.40 (range: 0.6–2.0) mg/dl, respectively. Four patients died (range: 0.1–1.3 years), and median postoperative follow-up among the 18 ongoing survivors (at last follow-up) was 1.5 (range: 0.5–7.0) years. Conclusions Resection of right RCC with an obstructing level II–IV TT without reconstruction of the IVC appears to not have a significant adverse effect on mid-term renal function after division of the left renal vein.
Collapse
Affiliation(s)
- Laura Horodyski
- Department of Urology, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Javier Gonzalez
- Servicio de Urologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Marina M. Tabbara
- Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States
- Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, United States
| | - Jeffrey J. Gaynor
- Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States
- Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, United States
| | | | - Felipe Herranz-Amo
- Servicio de Urologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Carlos Hernández
- Servicio de Urologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Rushi Shah
- Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States
- Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, United States
| | - Gaetano Ciancio
- Department of Urology, University of Miami Miller School of Medicine, Miami, FL, United States
- Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States
- Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, United States
- *Correspondence: Gaetano Ciancio,
| |
Collapse
|
12
|
Arroyo MI, Gómez L, Hernández C, Agudelo D, Galván-Diaz AL, Velásquez LE. Prevalencia de Fasciola hepatica y Paramphistomidae en bovinos de doble propósito en una hacienda del trópico bajo andino colombiano Digeneos en bovinos de doble propósito del trópico bajo andino colombiano. Rev Med Vet Zoot 2022. [DOI: 10.15446/rfmvz.v69n1.101530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
En muchos países la fasciolosis y paramfistomosis representan un grave problema para la salud del sector pecuario. En Colombia hay registros de ambas distomatosis en bovinos, de la mayoría del trópico alto andino, las cuales generan pérdidas económicas anuales cercanas a 40 000 000 000 COP. El objetivo de esta investigación fue determinar la prevalencia de fasciolosis y paramfistomosis en vacunos de la hacienda La Candelaria, Caucasia (Colombia), y la presencia de caracoles hospederos intermediarios. Para cumplirlo, se realizó un estudio descriptivo de corte transversal con muestreo no probabilístico por conveniencia. Se recolectaron heces de los animales y se hizo el diagnóstico mediante la técnica modificada de Dennis. Se establecieron las prevalencias de los digeneos de acuerdo con el sexo, peso, edad y raza. Se recolectaron caracoles dulciacuícolas en la zona estudiada y se identificaron por morfología. Se analizaron 466 muestras fecales de 178 bovinos, de las razas Cebú (Bos indicus), BON (blanco orejinegro) y del cruce entre ellas. Se diagnosticaron F. hepatica y Paramphistomidae con prevalencias del 2,2% y 30,9%, respectivamente. En el 1,1% de los vacunos se diagnosticó coinfección. Ambas trematodosis prevalecieron en las hembras (p = 0,03). Se identificaron moluscos dulciacuícolas Ampullariidae, Physidae y Planorbidae sin estadios larvarios de digeneos. Se concluyó que los bovinos de doble propósito de la hacienda La Candelaria están expuestos a F. hepatica y Paramphistomidae, y, probablemente, se infectan en los predios de la hacienda. Paramphistomidae es más prevalente que F. hepatica, lo cual concuerda con lo descrito en algunos estudios
Collapse
|
13
|
Moreno-Torres V, de Mendoza C, de la Fuente S, Sánchez E, Martínez-Urbistondo M, Herráiz J, Gutiérrez A, Gutiérrez Á, Hernández C, Callejas A, Maínez C, Royuela A, Cuervas-Mons V. Bacterial infections in patients hospitalized with COVID-19. Intern Emerg Med 2022; 17:431-438. [PMID: 34406633 PMCID: PMC8371593 DOI: 10.1007/s11739-021-02824-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Accepted: 08/02/2021] [Indexed: 02/05/2023]
Abstract
Bacterial infections may complicate the course of COVID-19 patients. The rate and predictors of bacterial infections were examined in patients consecutively admitted with COVID-19 at one tertiary hospital in Madrid between March 1st and April 30th, 2020. Among 1594 hospitalized patients with COVID-19, 135 (8.5%) experienced bacterial infectious events, distributed as follows: urinary tract infections (32.6%), bacteremia (31.9%), pneumonia (31.8%), intra-abdominal infections (6.7%) and skin and soft tissue infections (6.7%). Independent predictors of bacterial infections were older age, neurological disease, prior immunosuppression and ICU admission (p < 0.05). Patients with bacterial infections who more frequently received steroids and tocilizumab, progressed to lower Sap02/FiO2 ratios, and experienced more severe ARDS (p < 0.001). The mortality rate was significantly higher in patients with bacterial infections as compared to the rest (25% vs 6.7%, respectively; p < 0.001). In multivariate analyses, older age, prior neurological or kidney disease, immunosuppression and ARDS severity were associated with an increased mortality (p < 0.05) while bacterial infections were not. Conversely, the use of steroids or steroids plus tocilizumab did not confer a higher risk of bacterial infections and improved survival rates. Bacterial infections occurred in 8.5% of patients hospitalized with COVID-19 during the first wave of the pandemic. They were not independently associated with increased mortality rates. Baseline COVID-19 severity rather than the incidence of bacterial infections seems to contribute to mortality. When indicated, the use of steroids or steroids plus tocilizumab might improve survival in this population.
Collapse
Affiliation(s)
- Víctor Moreno-Torres
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
| | - Carmen de Mendoza
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
- CEU-San Pablo, University, Madrid, Spain.
| | - Sara de la Fuente
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Enrique Sánchez
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | | | - Jesús Herráiz
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Andrea Gutiérrez
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Ángela Gutiérrez
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Carlos Hernández
- Pharmacy Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
| | - Alejandro Callejas
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Carmen Maínez
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | - Ana Royuela
- Clinical Biostatistics Unit, Health Research Institute Puerta de Hierro-Segovia de Arana, CIBERESP, Madrid, Spain
| | - Valentín Cuervas-Mons
- Internal Medicine Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
- Universidad Autónoma de Madrid, Madrid, Spain
| |
Collapse
|
14
|
Flores B, Ramírez E, Moncada A, Salinas N, Fischer R, Hernández C, Mora-Sánchez B, Sheleby-Elías J, Jirón W, Balcázar JL. Antimicrobial effect of Moringa oleifera seed powder against Vibrio cholerae isolated from the rearing water of shrimp (Penaeus vannamei) postlarvae. Lett Appl Microbiol 2021; 74:238-246. [PMID: 34806784 DOI: 10.1111/lam.13604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 10/01/2021] [Accepted: 11/02/2021] [Indexed: 11/29/2022]
Abstract
Shrimp farming has experienced rising costs as a result of disease outbreaks associated with Vibrio spp. Suitable strategies for disease prevention and control are therefore urgently needed. This study aimed to evaluate the antimicrobial effect of Moringa oleifera seed powder against Vibrio cholerae in the rearing water of Pacific white shrimp (Penaeus vannamei) postlarvae. In vitro assays included the determination of minimum inhibitory concentration (MIC) of M. oleifera seed powder against V. cholerae, whereas in vivo assays included the effect of M. oleifera seed powder on bacterial load and water quality parameters in the rearing tanks, as well as its effect on shrimp postlarvae survival. M. oleifera seed powder inhibited the growth of V. cholerae with MIC values of 62·5 µg ml-1 . Moreover, seawater pH of treated tanks (8·66) was significantly lower (P < 0·01) than pH of the control tanks (9·02), whereas the visibility of treated tanks (37·08 cm) was significantly higher (P < 0·01) as compared to control tanks (35·37 cm). Likewise, V. cholerae load was significantly reduced (P < 0·01) from 4·7 × 104 to 3·1 × 103 CFU per ml in tanks treated with M. oleifera seed powder. Altogether, this study demonstrates the antimicrobial activity of M. oleifera against V. cholerae in shrimp culture.
Collapse
Affiliation(s)
- B Flores
- Centro Veterinario de Diagnóstico e Investigación (CEVEDI), Departamento de Veterinaria y Zootecnia, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - E Ramírez
- Departamento Acuícola, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - A Moncada
- Departamento Acuícola, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - N Salinas
- Departamento Acuícola, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - R Fischer
- Department of Epidemiology and Biostatistics, Texas A & M University Health Science Center, College Station, TX, USA
| | - C Hernández
- Departamento Acuícola, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - B Mora-Sánchez
- Centro Veterinario de Diagnóstico e Investigación (CEVEDI), Departamento de Veterinaria y Zootecnia, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua.,Department of Animal Pathology, Faculty of Veterinary Sciences, Universidad de Zaragoza, Zaragoza, Spain
| | - J Sheleby-Elías
- Centro Veterinario de Diagnóstico e Investigación (CEVEDI), Departamento de Veterinaria y Zootecnia, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - W Jirón
- Centro Veterinario de Diagnóstico e Investigación (CEVEDI), Departamento de Veterinaria y Zootecnia, Escuela de Ciencias Agrarias y Veterinarias, Universidad Nacional Autónoma de Nicaragua-León (UNAN-León), León, Nicaragua
| | - J L Balcázar
- Catalan Institute for Water Research (ICRA), Girona, Spain
| |
Collapse
|
15
|
Palmeiro E, Ibañez M, Hernández C, Chocarro L, Arasanz H, Bocanegra A, Fernandez J, Santamaria E, Vera R, Smerdou C, Escors D, Kochan G. 24P The STAT3 phosphorylation status discriminates tumor associated populations in myeloid cell tumor-infiltrating model. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
16
|
Cuñat T, Martínez-Pastor JC, Dürsteler C, Hernández C, Sala-Blanch X. Perioperative medicine role in painful knee prosthesis prevention. Rev Esp Anestesiol Reanim (Engl Ed) 2021; 69:S0034-9356(21)00142-0. [PMID: 34325900 DOI: 10.1016/j.redar.2021.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 01/07/2021] [Accepted: 03/25/2021] [Indexed: 11/25/2022]
Abstract
Total knee arthroplasty is one of the most frequently performed orthopaedic surgeries. However, up to 20% of patients develop persistent postoperative pain. Persistent postoperative pain may be an extension of acute postoperative pain, but can also occur after more than 3 months without symptoms. Risk factors associated with persistent postoperative pain after arthroplasty have now been characterised within the patient's perioperative context (preoperative, intraoperative and postoperative), and can be grouped under genetic, demographic, clinical, surgical, analgesic, inflammatory and psychological factors. Identification and prevention of persistent postoperative pain through a multimodal and biopsychosocial approach is essential in the context of perioperative medicine, and has been shown to prevent or ameliorate postoperative pain.
Collapse
Affiliation(s)
- T Cuñat
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, España.
| | - J C Martínez-Pastor
- Servicio de Traumatología y Cirugía Ortopédica, Hospital Clínic de Barcelona, Barcelona, España
| | - C Dürsteler
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, España
| | - C Hernández
- Servicio de Anestesiología y Reanimación, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Barcelona, España
| | - X Sala-Blanch
- Servicio de Anestesiología, Reanimación y Tratamiento del dolor, Hospital Clínic de Barcelona, Barcelona, España
| |
Collapse
|
17
|
Barros-Tornay R, Ferrándiz L, Martín-Gutiérrez FJ, Fernández-Orland A, Serrano-Gotarredona A, de la Torre JM, Conejo-Mir MD, Ojeda-Vila T, Márquez-Enríquez J, Hernández C, Ocaña MJ, Herrerías-Esteban JM, Moreno-Ramírez D. Feasibility and cost of a telemedicine-based short-term plan for initial access in general dermatology in Andalusia, Spain. JAAD Int 2021; 4:52-57. [PMID: 34409393 PMCID: PMC8362296 DOI: 10.1016/j.jdin.2021.05.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/12/2021] [Indexed: 01/30/2023] Open
Abstract
Background In developed countries, health care delivery in dermatology is hampered by the low availability of dermatologists. Objective To analyze the feasibility of a teledermatology-based action plan to provide initial dermatologic care in areas with low availability of dermatologists. Methods A cross-sectional study describing the feasibility and cost of a 12-month action plan based on a store-and-forward teledermatology (TD) connecting primary care centers and a TD center. Teleconsultations from patients complaining of any cutaneous condition were included. The primary outcome measure was the percentage of patients not referred to the local dermatologist. Results Among the total of 15,523 teleconsultations attended in the TD-based action plan, 3360 (21.65%) required a face-to-face visit with a local dermatologist. In 32.32% (n = 5017) of the cases, a therapeutic and follow-up plan report was issued. The most common conditions managed were melanocytic nevi (15.63%, n = 2426), followed by seborrheic keratosis (14.89%, n = 2312), and actinic keratosis (8.65%, n = 1342). The average response time was 14.52 days (95% CI 14.35-15.23). The additional total investment in this action plan was $142,681.01, with a unit cost of 9.20$/patient. Limitations Noncontrolled study. Conclusions Experienced dermatologists working with store-and-forward TD can deliver a fast and effective response in health care areas with access limitations.
Collapse
Affiliation(s)
- Ruben Barros-Tornay
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Lara Ferrándiz
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Francisco J Martín-Gutiérrez
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Almudena Fernández-Orland
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Amalia Serrano-Gotarredona
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - José M de la Torre
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - María D Conejo-Mir
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Teresa Ojeda-Vila
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | | | | | - María J Ocaña
- Dermatology Unit, Hospital San Agustín, Linares, Spain
| | | | - David Moreno-Ramírez
- Teledermatology Group, Department of Medical-&-Surgical Dermatology, Hospital Universitario Virgen Macarena, Sevilla, Spain
| |
Collapse
|
18
|
Polanco L, Bueno G, Caño J, Rodríguez E, Diez-Cordero J, Hernández J, Blaha I, Hernández C. Laparoscopic pyelolithotomy in pelvic ectopic kidney: Case report and literature review. Actas Urol Esp 2021. [PMID: 33676772 DOI: 10.1016/j.acuro.2020.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Pelvic kidney is a rare congenital anomaly. The ectopic kidney is more susceptible to developing lithiasis. The management of this type of lithiasis is a challenge. The objective of this paper was to conduct a review of available literature on the treatment of stone in ectopic kidney. MATERIAL AND METHODS Description of a case of transperitoneal laparoscopic pyelolithotomy for the treatment of inferior calyceal lithiasis in a right pelvic kidney. A literature review was performed by using Pubmed. The following terms and combination terms were searched: «pelvic ectopic kidney», «ureterorenoscopy», «extracorporeal lithotripsy», «PCNL», «pyelolithotomy». We included original articles, meta-analysis, review and case reports. RESULTS 130 articles were excluded by title or duplication. 62 abstracts articles and them 50 full text articles were evaluated. Stone free rate were 75% (SLW), 85% (URSf), 85-90% (PCNL) and 100% (laparoscopic pyelolithotomy). The literature on treatment on pelvic kidney is poor. CONCLUSION Factors such stone size, density and location, and upper urinary tract abnormalities, influence the choice of therapeutic approach (retrograde, percutaneous and/or laparoscopic/robotic). Laparoscopic pyelolithotomy is a safe and minimally invasive treatment option for large kidney stones with unfavorable anatomy for the endoscopic approach.
Collapse
|
19
|
Milić M, Ceppi M, Bruzzone M, Azqueta A, Brunborg G, Godschalk R, Koppen G, Langie S, Møller P, Teixeira JP, Alija A, Anderson D, Andrade V, Andreoli C, Asllani F, Bangkoglu EE, Barančoková M, Basaran N, Boutet-Robinet E, Buschini A, Cavallo D, Costa Pereira C, Costa C, Costa S, Da Silva J, Del Boˊ C, Dimitrijević Srećković V, Djelić N, Dobrzyńska M, Duračková Z, Dvořáková M, Gajski G, Galati S, García Lima O, Giovannelli L, Goroshinskaya IA, Grindel A, Gutzkow KB, Hernández A, Hernández C, Holven KB, Ibero-Baraibar I, Ottestad I, Kadioglu E, Kažimirová A, Kuznetsova E, Ladeira C, Laffon B, Lamonaca P, Lebailly P, Louro H, Mandina Cardoso T, Marcon F, Marcos R, Moretti M, Moretti S, Najafzadeh M, Nemeth Z, Neri M, Novotna B, Orlow I, Paduchova Z, Pastor S, Perdry H, Spremo-Potparević B, Ramadhani D, Riso P, Rohr P, Rojas E, Rossner P, Safar A, Sardas S, Silva MJ, Sirota N, Smolkova B, Staruchova M, Stetina R, Stopper H, Surikova EI, Ulven SM, Ursini CL, Valdiglesias V, Valverde M, Vodicka P, Volkovova K, Wagner KH, Živković L, Dušinská M, Collins AR, Bonassi S. The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confounders. Mutat Res Rev Mutat Res 2021; 787:108371. [PMID: 34083035 PMCID: PMC8525632 DOI: 10.1016/j.mrrev.2021.108371] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/09/2020] [Revised: 01/25/2021] [Accepted: 01/27/2021] [Indexed: 01/11/2023]
Abstract
The alkaline comet assay, or single cell gel electrophoresis, is one of the most popular methods for assessing DNA damage in human population. One of the open issues concerning this assay is the identification of those factors that can explain the large inter-individual and inter-laboratory variation. International collaborative initiatives such as the hCOMET project - a COST Action launched in 2016 - represent a valuable tool to meet this challenge. The aims of hCOMET were to establish reference values for the level of DNA damage in humans, to investigate the effect of host factors, lifestyle and exposure to genotoxic agents, and to compare different sources of assay variability. A database of 19,320 subjects was generated, pooling data from 105 studies run by 44 laboratories in 26 countries between 1999 and 2019. A mixed random effect log-linear model, in parallel with a classic meta-analysis, was applied to take into account the extensive heterogeneity of data, due to descriptor, specimen and protocol variability. As a result of this analysis interquartile intervals of DNA strand breaks (which includes alkali-labile sites) were reported for tail intensity, tail length, and tail moment (comet assay descriptors). A small variation by age was reported in some datasets, suggesting higher DNA damage in oldest age-classes, while no effect could be shown for sex or smoking habit, although the lack of data on heavy smokers has still to be considered. Finally, highly significant differences in DNA damage were found for most exposures investigated in specific studies. In conclusion, these data, which confirm that DNA damage measured by the comet assay is an excellent biomarker of exposure in several conditions, may contribute to improving the quality of study design and to the standardization of results of the comet assay in human populations.
Collapse
Affiliation(s)
- Mirta Milić
- Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000, Zagreb, Croatia
| | - Marcello Ceppi
- Biostatistics Unit, San Martino Policlinic Hospital, Genoa, Italy
| | - Marco Bruzzone
- Biostatistics Unit, San Martino Policlinic Hospital, Genoa, Italy
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, C/Irunlarrea 3, 31008, Pamplona, Spain
| | - Gunnar Brunborg
- Department of Environmental Health, Section of Molecular Toxicology, Norwegian Institute of Public Health (NIPH), Lovisenberggt 6, 0456, Oslo, Norway
| | - Roger Godschalk
- School of Nutrition and Translational Research in Metabolism, Department of Pharmacology and Toxicology, University of Maastricht, Universiteitssingel 50, 6200 MD, Maastricht, the Netherlands
| | - Gudrun Koppen
- Flemish Institute of Technological Research, Environmental Risk and Health unit VITO - BIOMo, Belgium
| | - Sabine Langie
- School of Nutrition and Translational Research in Metabolism, Department of Pharmacology and Toxicology, University of Maastricht, Universiteitssingel 50, 6200 MD, Maastricht, the Netherlands
| | - Peter Møller
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Oster Farimagsgade 5A, DK-1014, Copenhagen, Denmark
| | - João Paulo Teixeira
- Environmental Health Department, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055, Porto, Portugal; EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, no 135, 4050-600, Porto, Portugal
| | - Avdulla Alija
- Department of Biology, University of Prishtina, George Bush, N.N., 10000, Prishtina, Kosovo
| | - Diana Anderson
- Biomedical Sciences Department, University of Bradford, Richmond Road Bradford, Bradford, West Yorkshire, BD7 1DP, UK
| | - Vanessa Andrade
- Laboratory of Translational Biomedicine, University of Southern Santa Catarina, UNESC, Criciúma, SC, Brazil
| | - Cristina Andreoli
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy
| | - Fisnik Asllani
- Department of Biology, University of Prishtina, George Bush, N.N., 10000, Prishtina, Kosovo
| | - Ezgi Eyluel Bangkoglu
- Institute of Pharmacology and Toxicology, University of Wuerzburg, VersbacherStrasse 9, 97078, Wuerzburg, Germany
| | - Magdalena Barančoková
- Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia
| | - Nursen Basaran
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
| | - Elisa Boutet-Robinet
- Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France
| | - Annamaria Buschini
- Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area delle Scienze 11A, 43124, Parma, Italy
| | - Delia Cavallo
- Department of Occupational and Environmental Medicine, Epidemiology and Hygiene (DiMEILA), Italian Workers' Compensation Authority (INAIL), Via Fontana Candida 1, 00078, Monte Porzio Catone(Rome), Italy
| | - Cristiana Costa Pereira
- Environmental Health Department, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055, Porto, Portugal; EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, no 135, 4050-600, Porto, Portugal
| | - Carla Costa
- Environmental Health Department, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055, Porto, Portugal; EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, no 135, 4050-600, Porto, Portugal
| | - Solange Costa
- Environmental Health Department, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055, Porto, Portugal; EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, no 135, 4050-600, Porto, Portugal
| | - Juliana Da Silva
- Laboratory of Genetic Toxicology, Lutheran University of Brazil (ULBRA), Av. Farroupilha 8001, Prédio 22/Sala 22, 92425-900, Canoas, RS, Brazil
| | - Cristian Del Boˊ
- Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133, Milan, Italy
| | - Vesna Dimitrijević Srećković
- Faculty of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Disease, University of Belgrade, Dr Subotića 13, Belgrade, Serbia
| | - Ninoslav Djelić
- Department of Biology, Faculty of Veterinary Medicine, University of Belgrade, Oslobodjenja Blvd 18, 11000, Belgrade, Serbia
| | - Malgorzata Dobrzyńska
- Department of Radiation Hygiene and Radiobiology, National Institute of Public Health - National Institute of Hygiene, 24 Chocimska Street, 00-791, Warsaw, Poland
| | - Zdenka Duračková
- Institute for Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Sasinkova 2, Bratislava, Slovakia
| | - Monika Dvořáková
- Institute for Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Sasinkova 2, Bratislava, Slovakia
| | - Goran Gajski
- Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000, Zagreb, Croatia
| | - Serena Galati
- Centre for Molecular and Translational Oncology, University of Parma, Parco Area delle Scienze 11A, 43124, Parma, Italy
| | - Omar García Lima
- Center for RadiationProtection and Hygiene, Calle 20, No 4113, e/41 y 47. Playa. C.P. 11300, La Habana, A.P. 6195, C.P. 10600, Habana, Cuba
| | - Lisa Giovannelli
- Department NEUROFARBA, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy
| | - Irina A Goroshinskaya
- Laboratory for the Study of the Pathogenesis of Malignant Tumors, National Medical Research Center for Oncology, 14 line 63, 344037, Rostov-on-Don, Russia
| | - Annemarie Grindel
- Department of Nutritional Sciences, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria
| | - Kristine B Gutzkow
- Department of Environmental Health, Section of Molecular Toxicology, Norwegian Institute of Public Health (NIPH), Lovisenberggt 6, 0456, Oslo, Norway
| | - Alba Hernández
- Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, 28029, Madrid, Spain
| | - Carlos Hernández
- Department of Biochemistry, Instituto de Ciencias Básicas y Preclínicas "Victoria de Giron", 146 St. and 31 Ave, No 3102, Playa, Habana, Cuba
| | - Kirsten B Holven
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Idoia Ibero-Baraibar
- Department of Nutrition, Food Science and Physiology, Centre for Nutrition Research, University of Navarra, Irunlarrea 1, 31008, Pamplona, Navarra, Spain
| | - Inger Ottestad
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Ela Kadioglu
- Toxicology Department, Faculty of Pharmacy, Gazi University, Ankara, Turkey
| | - Alena Kažimirová
- Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia
| | - Elena Kuznetsova
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290, Institutskaya 3, Pushchino, Moscow Region, Russia
| | - Carina Ladeira
- H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096, Lisbon, Portugal; NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal
| | - Blanca Laffon
- Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Psicología, Facultad de Ciencias de la Educación, Universidade da Coruña, Campus Elviña s/n, 15071, A Coruña, Spain
| | - Palma Lamonaca
- IRCCS San Raffaele Pisana, Unit of Clinical and Molecular Epidemiology, Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Via di Val Cannuta, 247., 00161, Rome, Italy
| | - Pierre Lebailly
- ANTICIPE Unit, INSERM &University of Caen-Normandie Centre François Baclesse, Avenue du Général Harris 14076, Caen Cedex 05, France
| | - Henriqueta Louro
- Human Genetics Department, National Institute of Health Doutor Ricardo Jorge, Av. Padre Cruz, 1649-016, Lisbon, Portugal; ToxOmics, NMS, NOVA University of Lisbon, Lisbon, Portugal
| | - Tania Mandina Cardoso
- Center for RadiationProtection and Hygiene, Calle 20, No 4113, e/41 y 47. Playa. C.P. 11300, La Habana, A.P. 6195, C.P. 10600, Habana, Cuba
| | - Francesca Marcon
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy
| | - Ricard Marcos
- Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, 28029, Madrid, Spain
| | - Massimo Moretti
- Department of Pharmaceutical Sciences (Unit of Public Health), University of Perugia, Via del Giochetto, 06122, Perugia, Italy
| | - Silvia Moretti
- Department of Health Sciences, University of Florence, Division of Dermatology, Palagi Hospital, Viale Michelangelo 41, Florence, Italy
| | - Mojgan Najafzadeh
- Biomedical Sciences Department, University of Bradford, Richmond Road Bradford, Bradford, West Yorkshire, BD7 1DP, UK
| | - Zsuzsanna Nemeth
- Department of Non-ionizing Radiation, National Public Health Center, Anna Street 5, 1221, Budapest, Hungary
| | - Monica Neri
- IRCCS San Raffaele Pisana, Unit of Clinical and Molecular Epidemiology, Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Via di Val Cannuta, 247., 00161, Rome, Italy
| | - Bozena Novotna
- Department of Nanotoxicolgy and Molecular Epidemiology, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, Prague, Czech Republic
| | - Irene Orlow
- Memorial Sloan Kettering Cancer Center, Epidemiology and Biostatistics, New York, New York, 10065, USA
| | - Zuzana Paduchova
- Institute for Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Sasinkova 2, Bratislava, Slovakia
| | - Susana Pastor
- Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, 28029, Madrid, Spain
| | | | - Biljana Spremo-Potparević
- Center of Biological Research, Faculty of Pharmacy, University of Belgrade, VojvodeStepe, 450, Belgrade, Serbia
| | - Dwi Ramadhani
- Center for Radiation Safety Technology and Metrology, National Nuclear Energy Agency of Indonesia, Jl. LebakBulus Raya No. 49, Kotak Pos 7043 JKSKL JakartaSelatan, 12440, Jakarta, Indonesia
| | - Patrizia Riso
- Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133, Milan, Italy
| | - Paula Rohr
- Laboratory of Translational Biomedicine, University of Southern Santa Catarina, UNESC, Criciúma, SC, Brazil
| | - Emilio Rojas
- Genomic Medicine and EnvironmentalToxicology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, CU, Mexico
| | - Pavel Rossner
- Department of Nanotoxicolgy and Molecular Epidemiology, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, Prague, Czech Republic
| | - Anna Safar
- Department of Non-ionizing Radiation, National Public Health Center, Anna Street 5, 1221, Budapest, Hungary
| | - Semra Sardas
- Toxicology Department, Faculty of Pharmacy, Istinye University, Istanbul, Turkey
| | - Maria João Silva
- Human Genetics Department, National Institute of Health Doutor Ricardo Jorge, Av. Padre Cruz, 1649-016, Lisbon, Portugal; ToxOmics, NMS, NOVA University of Lisbon, Lisbon, Portugal
| | - Nikolay Sirota
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290, Institutskaya 3, Pushchino, Moscow Region, Russia
| | - Bozena Smolkova
- Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia
| | - Marta Staruchova
- Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia
| | - Rudolf Stetina
- Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
| | - Helga Stopper
- Institute of Pharmacology and Toxicology, University of Wuerzburg, VersbacherStrasse 9, 97078, Wuerzburg, Germany
| | - Ekaterina I Surikova
- Laboratory for the Study of the Pathogenesis of Malignant Tumors, National Medical Research Center for Oncology, 14 line 63, 344037, Rostov-on-Don, Russia
| | - Stine M Ulven
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Cinzia Lucia Ursini
- Department of Occupational and Environmental Medicine, Epidemiology and Hygiene (DiMEILA), Italian Workers' Compensation Authority (INAIL), Via Fontana Candida 1, 00078, Monte Porzio Catone(Rome), Italy
| | - Vanessa Valdiglesias
- Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Biología, Facultad de Ciencias, Universidade da Coruña, Campus A Zapateira s/n, 15071, A Coruña, Spain
| | - Mahara Valverde
- Genomic Medicine and EnvironmentalToxicology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, CU, Mexico
| | - Pavel Vodicka
- Experimental Medicine, Molecular Biology of Cancer, IEM AVCR, Videnska 1083, Prague 4, Prague, Czech Republic
| | - Katarina Volkovova
- Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia
| | - Karl-Heinz Wagner
- Department of Nutritional Sciences, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria
| | - Lada Živković
- Center of Biological Research, Faculty of Pharmacy, University of Belgrade, VojvodeStepe, 450, Belgrade, Serbia
| | | | - Andrew R Collins
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Stefano Bonassi
- IRCCS San Raffaele Pisana, Unit of Clinical and Molecular Epidemiology, Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Via di Val Cannuta, 247., 00161, Rome, Italy.
| |
Collapse
|
20
|
Cózar JM, Hernández C, Miñana B, Morote J, Alvarez-Cubero MJ. The role of prostate-specific antigen in light of new scientific evidence: An update in 2020. Actas Urol Esp 2021; 45:21-29. [PMID: 33408046 DOI: 10.1016/j.acuro.2020.09.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Accepted: 09/23/2020] [Indexed: 12/19/2022]
Abstract
OBJECTIVE To review and update the latest scientific evidence gathered in recent years regarding prostate-specific antigen (PSA) for better implementation into routine clinical practice. EVIDENCE ACQUISITION Analysis of the available evidence on the current role of PSA, based on the experience of an expert panel in the subject under analysis. EVIDENCE SYNTHESIS Currently, PSA cannot be considered only as a guide for the presence or absence of prostate cancer. This determination can also help the urologist to decide on the most convenient treatment for a patient with benign prostatic hypertrophy (BPH) as a criterion for disease progression, and it can also suggest the suspicious existence of a prostatic tumor when there is PSA rise of>0.3 ng/ml over the level reached 6 months after having initiated treatment with 5-alpha-reductase inhibitor. However, the limits of this PSA rise with derivatives of alternative 5-alpha-reductase (5-ARI) inhibitors to dutasteride are controversial. Moreover, PSA is a key factor for the follow-up of patients with prostate adenocarcinoma at any stage who have received treatment (surgery, radiotherapy or focal therapies, hormone therapy), it acts as a guide to identify biochemical recurrence, to suspect the existence of local or distant recurrence, as well as to propose or discard adjuvant treatments. Finally, the role of PSA as a screening tool has been recently reinforced, demonstrating increased mortality rates or the existence of more aggressive cases of prostate cancer in those countries where the use of this tool has declined. CONCLUSIONS We present new data about the current role of PSA in the management of patients treated for BPH and/or prostate cancer that should be implemented into routine clinical practice, with special emphasis on the relevant role of this biomarker in the screening and follow-up of prostate cancer, as well as in the progression of BPH in dutasteride treatment.
Collapse
Affiliation(s)
- J M Cózar
- Servicio de Urología, Hospital Universitario Virgen de la Nieves, Granada, España; Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, España.
| | - C Hernández
- Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, España
| | - B Miñana
- Servicio de Urología, Hospital CUN de Madrid, Madrid, España
| | - J Morote
- Servicio de Urología, Hospital Universitario Vall de Hebrón, Barcelona, España
| | - M J Alvarez-Cubero
- Departamento de Bioquímica y Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Granada, Granada, España
| |
Collapse
|
21
|
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló García A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín M, Castellví J, Mata A. Ways to perform an endoscopic tattoo. Prospective and randomized study in patients with colorectal neoplasm. Rev Esp Enferm Dig 2020; 113:519-523. [PMID: 33256420 DOI: 10.17235/reed.2020.7310/2020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
BACKGROUND AND AIMS intraoperative identification of colonic lesions previously detected via colonoscopy may be difficult. Endoscopic tattooing facilitates identification, but there is no evidence regarding which is the best tattoo technique. The goal of the study was to describe the efficacy and safety of endoscopic tattooing and to detect technical and clinical factors associated with its efficacy. PATIENTS AND METHODS a prospective and randomized study was performed. All tattoo candidate patients were included prior to surgery and randomized into four groups; tattoo at two or three injection points and with a volume of 1 or 1.5 ml of labeling. Multiple variables were registered. RESULTS one hundred and ninety-five patients were included with an endoscopic tattoo and who subsequently underwent a surgical intervention, the mean age was 70.1 years and 67.2 % were male. The laparoscopic approach was applied in 57.9 % of cases. The intraoperative visibility of the endoscopic tattoo was 89.7 % and 30 % of rectal lesions were not visible. Excluding the rectum, the marking was visible intraoperatively in 92 % of patients, without significant differences according to the surgical approach, the type of marking or any of the variables collected. The tattoo was safe in 92.3 % of the cases. The adverse effect rate was 7.7 % and none of the complications were clinically significant. There were no significant differences between any variables collected in relation to adverse effects. CONCLUSIONS endoscopic colon tattoo is safe and effective regardless of the technique used. We recommend the technique of two injection points and 1 ml of marking volume for its simplicity, efficiency and safety.
Collapse
Affiliation(s)
- David Barquero
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi, España
| | | | - Orlando García
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | | | | | - Mercè Navarro
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | | | - Marta Martín
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | - Eva Erice
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | - Xavier Ariza
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | | | - Celia Vascónez
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| | - Montse Martín
- Epidemiology and Statistics, Hospital de Sant Joan Despí Moisès Broggi
| | | | - Alfredo Mata
- Gastroenterology, Hospital de Sant Joan Despí Moisès Broggi
| |
Collapse
|
22
|
Hernández C, Olmeda-Guerrero L, Chávez-Sánchez M, Ibarra-Castro L, Gaxiola-Cortez G, Martínez-Cárdenas L. Nutritional evaluation of canola meal as fish meal replacement for juvenile spotted rose snapper (Lutjanus guttatus): Effects on growth performance, hematological parameters, body composition, and nutrient digestibility. Anim Feed Sci Technol 2020. [DOI: 10.1016/j.anifeedsci.2020.114683] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Gisbert-Ferrándiz L, Cosin-Roger J, Hernández C, Macias-Ceja DC, Ortiz-Masiá D, Salvador P, Wildenberg ME, Esplugues JV, Alós R, Navarro F, Calatayud S, Barrachina MD. The vitamin D receptor Taq I polymorphism is associated with reduced VDR and increased PDIA3 protein levels in human intestinal fibroblasts. J Steroid Biochem Mol Biol 2020; 202:105720. [PMID: 32565249 DOI: 10.1016/j.jsbmb.2020.105720] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 05/12/2020] [Accepted: 06/14/2020] [Indexed: 12/19/2022]
Abstract
The synonymous single nucleotide polymorphism (SNP) rs731236, located in the vitamin D receptor (VDR) gene (Taq I) has been associated with both decreased levels of the protein in peripheral blood mononuclear cells and a fibrosis-related complication in Crohn´s disease (CD). Interactions between VDR and a protein-disulfide isomerase-associated 3 (PDIA3) in the regulation of extracellular matrix have been reported and we aim to analyze the relevance of the VDR genotypes and the effects of Vitamin D (VD) in the expression of VDR, PDIA3 and proliferation of intestinal fibroblasts. Human intestinal fibroblasts were isolated from the non-affected surgical resections of colorectal patients and classified according to the VDR genotype. In some cases, cells were transfected with specific PDIA3 siRNA. Basal and VD-stimulated expression of VDR, PDIA3 and Collagen 1A1 (COL1A1) as well as fibroblast migration/proliferation were analyzed. Our data show that intestinal fibroblasts homozygous for the C allele in the VDR gene exhibited lower VDR protein levels and higher proliferation than cells homozygous for the T allele. VD increased VDR and attenuated the accelerated proliferation of CC fibroblasts. The diminished VDR level detected in CC cells was associated with increased levels of both PDIA3 and COL1A1 expression and the transient silencing of PDIA3 significantly reduced COL1A1 expression. We conclude that intestinal fibroblasts homozygous for the C allele in the VDR gene exhibited: reduced VDR protein levels, increased proliferation and increased PDIA3/COL1A1 expression. Treatment with VD increased VDR and attenuated proliferation of these cells.
Collapse
Affiliation(s)
- Laura Gisbert-Ferrándiz
- Departamento De Farmacología and CIBER, Facultad De Medicina, Universidad De Valencia, Valencia, Spain
| | | | | | | | - Dolores Ortiz-Masiá
- Departamento De Medicina, Facultad De Medicina, Universidad De Valencia, Valencia, Spain
| | - Pedro Salvador
- Departamento De Farmacología and CIBER, Facultad De Medicina, Universidad De Valencia, Valencia, Spain
| | - M E Wildenberg
- Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Juan V Esplugues
- Departamento De Farmacología and CIBER, Facultad De Medicina, Universidad De Valencia, Valencia, Spain; FISABIO, Valencia, Spain
| | | | | | - Sara Calatayud
- Departamento De Farmacología and CIBER, Facultad De Medicina, Universidad De Valencia, Valencia, Spain
| | - María D Barrachina
- Departamento De Farmacología and CIBER, Facultad De Medicina, Universidad De Valencia, Valencia, Spain.
| |
Collapse
|
24
|
Albendea P, Sierra I, Hernández C, Barrado A, Yllera A. Natural uranium isotopes determination in 24h-urine samples from exposed workers to enriched uranium. Radiat Phys Chem Oxf Engl 1993 2020. [DOI: 10.1016/j.radphyschem.2020.108929] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
25
|
Riba M, Bejarano M, Hernández C, Moraleda I, Massaguer C, Ribalta T, Gómez M, Krauel L, Parri FJ, Albert A. Midline Cervical Cleft: An Anatomical Finding and a Proposal for a New Approach. Cleft Palate Craniofac J 2020; 57:1422-1427. [PMID: 32806933 DOI: 10.1177/1055665620947957] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Congenital midline cervical cleft is a rare malformation. Typical case shows an area of hypotrophic skin, a cranial nipple-like structure, and a caudal blind sinus. Cervical extension is limited. Relapse of the retraction is common following cutaneous z-plasty. The aim of this study is to describe the radiological, surgical, and histological findings of the 4 cases treated in our center in the last 8 years and communicate the finding of a contractile structure, anterior to the platysma, composed by striated muscle, figure not previously described. This distinct muscular band is responsible for neck retraction. Removal of this releases cervical tension and is essential to avoid the relapse.
Collapse
Affiliation(s)
- Mireia Riba
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Miguel Bejarano
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Carlos Hernández
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain.,Department of Pediatric Surgery, 156300Hospital Universitario de Burgos, Spain
| | - Inés Moraleda
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Clara Massaguer
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Teresa Ribalta
- Department of Pathological Anatomy, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Marta Gómez
- Department of Radiology, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Lucas Krauel
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Francisco J Parri
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| | - Asteria Albert
- Department of Pediatric Surgery, 16512Hospital Sant Joan de Déu, University of Barcelona, Spain
| |
Collapse
|
26
|
Penson RT, Valencia RV, Cibula D, Colombo N, Leath CA, Bidziński M, Kim JW, Nam JH, Madry R, Hernández C, Mora PAR, Ryu SY, Milenkova T, Lowe ES, Barker L, Scambia G. Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial. J Clin Oncol 2020; 38:1164-1174. [PMID: 32073956 PMCID: PMC7145583 DOI: 10.1200/jco.19.02745] [Citation(s) in RCA: 157] [Impact Index Per Article: 39.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
PURPOSE A phase II study (ClinicalTrials.gov identifier: NCT00628251) showed activity of olaparib capsules versus pegylated liposomal doxorubicin in patients with germline BRCA-mutated platinum-resistant or partially platinum-sensitive relapsed ovarian cancer. We conducted a phase III trial (SOLO3) of olaparib tablets versus nonplatinum chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer who had received at least 2 prior lines of platinum-based chemotherapy. PATIENTS AND METHODS In this randomized, open-label trial, patients were randomly assigned 2:1 to olaparib 300 mg twice a day or physician's choice single-agent nonplatinum chemotherapy (pegylated liposomal doxorubicin, paclitaxel, gemcitabine, or topotecan). The primary end point was objective response rate (ORR) in the measurable disease analysis set assessed by blinded independent central review (BICR). The key secondary end point was progression-free survival (PFS) assessed by BICR in the intent-to-treat population. RESULTS Of 266 randomly assigned patients, 178 were assigned to olaparib and 88 to chemotherapy. In patients with measurable disease (olaparib, n = 151; chemotherapy, n = 72), the BICR-assessed ORR was significantly higher with olaparib than with chemotherapy (72.2% v 51.4%; odds ratio [OR], 2.53 [95% CI, 1.40 to 4.58]; P = .002). In the subgroup who had received 2 prior lines of treatment, the ORR was 84.6% with olaparib and 61.5% with chemotherapy (OR, 3.44 [95% CI, 1.42 to 8.54]). BICR-assessed PFS also significantly favored olaparib versus chemotherapy (hazard ratio, 0.62 [95% CI, 0.43 to 0.91]; P = .013; median, 13.4 v 9.2 months). Adverse events were consistent with the established safety profiles of olaparib and chemotherapy. CONCLUSION Olaparib resulted in statistically significant and clinically relevant improvements in ORR and PFS compared with nonplatinum chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer who had received at least 2 prior lines of platinum-based chemotherapy.
Collapse
Affiliation(s)
- Richard T Penson
- Harvard Medical School and Massachusetts General Hospital, Boston, MA
| | | | - David Cibula
- First Faculty of Medicine, Charles University and General University, Prague, Czech Republic
| | - Nicoletta Colombo
- University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy
| | | | - Mariusz Bidziński
- Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
| | - Jae-Weon Kim
- Seoul National University Hospital, Seoul, South Korea
| | | | - Radoslaw Madry
- Medical University K. Marcinkowski and Clinical Hospital of the Transfiguration, Poznań, Poland
| | | | - Paulo A R Mora
- Instituto COI de Educação e Pesquisa, Rio de Janeiro, Brazil
| | - Sang Young Ryu
- Korea Institute of Radiological and Medical Sciences, Seoul, South Korea
| | | | | | | | - Giovanni Scambia
- Università Cattolica del Sacro Cuore-Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy
| |
Collapse
|
27
|
Arasanz H, Zuazo M, Bocanegra A, Gato M, Martínez-Aguillo M, Morilla I, Fernández G, Hernández B, López P, Alberdi N, Hernández C, Chocarro L, Teijeira L, Vera R, Kochan G, Escors D. Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics. Cancers (Basel) 2020; 12:cancers12020344. [PMID: 32033028 PMCID: PMC7073153 DOI: 10.3390/cancers12020344] [Citation(s) in RCA: 44] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 01/17/2020] [Accepted: 01/31/2020] [Indexed: 12/21/2022] Open
Abstract
Hyperprogressive disease (HPD) is an adverse outcome of immunotherapy consisting of an acceleration of tumor growth associated with prompt clinical deterioration. The definitions based on radiological evaluation present important technical limitations. No biomarkers have been identified yet. In this study, 70 metastatic NSCLC patients treated with anti-PD-1/PD-L1 immunotherapy after progression to platinum-based therapy were prospectively studied. Samples from peripheral blood were obtained before the first (baseline) and second cycles of treatment. Peripheral blood mononuclear cells (PBMCs) were isolated and differentiation stages of CD4 lymphocytes quantified by flow cytometry and correlated with HPD as identified with radiological criteria. A strong expansion of highly differentiated CD28- CD4 T lymphocytes (CD4 THD) between the first and second cycle of therapy was observed in HPD patients. After normalizing, the proportion of posttreatment/pretreatment CD4 THD was significantly higher in HPD when compared with the rest of patients (median 1.525 vs. 0.990; p = 0.0007), and also when stratifying by HPD, non-HPD progressors, and responders (1.525, 1.000 and 0.9700 respectively; p = 0.0025). A cut-off value of 1.3 identified HPD with 82% specificity and 70% sensitivity. An increase of CD28- CD4 T lymphocytes ≥ 1.3 (CD4 THD burst) was significantly associated with HPD (p = 0.008). The tumor growth ratio (TGR) was significantly higher in patients with expansion of CD4 THD burst compared to the rest of patients (median 2.67 vs. 0.86, p = 0.0049), and also when considering only progressors (median 2.67 vs. 1.03, p = 0.0126). A strong expansion of CD28- CD4 lymphocytes in peripheral blood within the first cycle of therapy is an early differential feature of HPD in NSCLC treated with immune-checkpoint inhibitors. The monitoring of T cell dynamics allows the early detection of this adverse outcome in clinical practice and complements radiological evaluation.
Collapse
Affiliation(s)
- Hugo Arasanz
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Miren Zuazo
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
| | - Ana Bocanegra
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
| | - María Gato
- Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdISNA), University of Navarra, Pio XII ave, 55, 31008 Pamplona, Spain;
| | - Maite Martínez-Aguillo
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Idoia Morilla
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Gonzalo Fernández
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Berta Hernández
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Paúl López
- Radiology Department, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (P.L.); (N.A.)
| | - Nerea Alberdi
- Radiology Department, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (P.L.); (N.A.)
| | - Carlos Hernández
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
| | - Luisa Chocarro
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
| | - Lucía Teijeira
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
| | - Ruth Vera
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain; (M.M.-A.); (I.M.); (B.H.); (L.T.)
- Correspondence: (R.V.); (G.K.); (D.E.); Tel.: +34-848-422162 (R.V.); +34-848-425742 (G.K. & D.E.)
| | - Grazyna Kochan
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
- Correspondence: (R.V.); (G.K.); (D.E.); Tel.: +34-848-422162 (R.V.); +34-848-425742 (G.K. & D.E.)
| | - David Escors
- Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain; (H.A.); (M.Z.); (A.B.); (G.F.); (C.H.); (L.C.)
- Correspondence: (R.V.); (G.K.); (D.E.); Tel.: +34-848-422162 (R.V.); +34-848-425742 (G.K. & D.E.)
| |
Collapse
|
28
|
Abstract
Grid path planning is an important problem in AI. Its understanding has been key for the development of autonomous navigation systems. An interesting and rather surprising fact about the vast literature on this problem is that only a few neighborhoods have been used when evaluating these algorithms. Indeed, only the 4- and 8-neighborhoods are usually considered, and rarely the 16-neighborhood. This paper describes three contributions that enable the construction of effective grid path planners for extended 2k-neighborhoods; that is, neighborhoods that admit 2k neighbors per state, where k is a parameter. First, we provide a simple recursive definition of the 2k-neighborhood in terms of the 2k-1-neighborhood. Second, we derive distance functions, for any k ≥ 2, which allow us to propose admissible heuristics that are perfect for obstacle-free grids, which generalize the well-known Manhattan and Octile distances. Third, we define the notion of canonical path for the 2k-neighborhood; this allows us to incorporate our neighborhoods into two versions of A*, namely Canonical A* and Jump Point Search (JPS), whose performance, we show, scales well when increasing k. Our empirical evaluation shows that, when increasing k, the cost of the solution found improves substantially. Used with the 2k-neighborhood, Canonical A* and JPS, in many configurations, are also superior to the any-angle path planner Theta* both in terms of solution quality and runtime. Our planner is competitive with one implementation of the any-angle path planner, ANYA in some configurations. Our main practical conclusion is that standard, well-understood grid path planning technology may provide an effective approach to any-angle grid path planning.
Collapse
|
29
|
Hernández C, Valdera CJ, Cordero J, López E, Plaza J, Albi M. Impact of telemedicine on assisted reproduction treatment in the public health system. J Healthc Qual Res 2019; 35:27-34. [PMID: 31883955 DOI: 10.1016/j.jhqr.2019.08.004] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2019] [Revised: 08/17/2019] [Accepted: 08/20/2019] [Indexed: 11/26/2022]
Abstract
AIM Telemedicine has helped to make health care more efficient. However, to date no studies have measured its impact on infertility and fertility healthcare. We assessed the potential care benefits and clinical advantages of an initiative implementing electronic patient portal (EPP) for patients scheduled to undergo assisted reproduction treatment, to reduce waiting times for medical consultation and treatment. METHODS This was designed as a retrospective cohort study. The experimental group comprised 1972 referral requests received by the assisted reproduction unit of our institution between 2015 and 2016, which were included in the group receiving telemedicine, while the control group was defined by 283 requests received in 2013, all of which were assigned face-to-face care. RESULTS We found a statistically significant reduction in the experimental group in terms of the days elapsed between the receipt of the assessment request and the first outpatient visit (68 days vs. 180 days, p<.001). Time to initiation of treatment was also significantly lower in this group (169 days vs. 229 days; p<.001). The experimental group contained around 7 times as many patients receiving treatment as the control group. No differences were observed in the pregnancy rate (29.9% vs. 31.1%; p=.77) or in the complication rate (3.2% vs. 0%; p=.16). CONCLUSIONS Use of telemedicine in electronic portal patient form reduces the total waiting time involved in patient requests for infertility treatment and indirectly increases the number of patients treated, causing no negative impact on treatment outcome.
Collapse
Affiliation(s)
- C Hernández
- Assisted Reproduction Unit, Fundación Jiménez Díaz, Madrid, Spain; Department of Obstetrics and Gynecology, Fundación Jiménez Díaz, Madrid, Spain
| | - C J Valdera
- Assisted Reproduction Unit, Fundación Jiménez Díaz, Madrid, Spain; Department of Obstetrics and Gynecology, Fundación Jiménez Díaz, Madrid, Spain.
| | - J Cordero
- Assisted Reproduction Unit, Fundación Jiménez Díaz, Madrid, Spain; Department of Obstetrics and Gynecology, Fundación Jiménez Díaz, Madrid, Spain
| | - E López
- Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - J Plaza
- Department of Obstetrics and Gynecology, Fundación Jiménez Díaz, Madrid, Spain
| | - M Albi
- Department of Obstetrics and Gynecology, Fundación Jiménez Díaz, Madrid, Spain
| |
Collapse
|
30
|
Bautista F, Cañete A, Ramírez-Villar GL, Fernández JM, Fuster JL, Diaz de Heredia C, Astigarraga I, García-Ariza M, Rives S, Dapena JL, Márquez C, Molinés A, Bermúdez MDM, Gallego S, Andrés MDM, Verdu-Amoros J, Hernández C, López M, Catalá A, Lassaletta Á, Cruz O, Ramírez M, Lendínez F, Carboné A, Gomez Sirvent J, Tallón M, Acha T, Moreno L, Fernández-Teijeiro A. ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain. Clin Transl Oncol 2019; 21:1763-1770. [DOI: 10.1007/s12094-019-02221-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Accepted: 09/27/2019] [Indexed: 10/25/2022]
Abstract
Abstract
Introduction
Cancer and blood disorders in children are rare. The progressive improvement in survival over the last decades largely relies on the development of international academic clinical trials that gather the sufficient number of patients globally to elaborate solid conclusions and drive changes in clinical practice. The participation of Spain into large international academic trials has traditionally lagged behind of other European countries, mainly due to the burden of administrative tasks to open new studies, lack of financial support and limited research infrastructure in our hospitals.
Methods
The objective of ECLIM-SEHOP platform (Ensayos Clínicos Internacionales Multicéntricos-SEHOP) is to overcome these difficulties and position Spain among the European countries leading the advances in cancer and blood disorders, facilitate the access of our patients to novel diagnostic and therapeutic approaches and, most importantly, continue to improve survival and reducing long-term sequelae. ECLIM-SEHOP provides to the Spanish clinical investigators with the necessary infrastructural support to open and implement academic clinical trials and registries.
Results
In less than 3 years from its inception, the platform has provided support to 20 clinical trials and 8 observational studies, including 8 trials and 4 observational studies where the platform performs all trial-related tasks (integral support: trial setup, monitoring, etc.) with more than 150 patients recruited since 2017 to these studies. In this manuscript, we provide baseline metrics for academic clinical trial performance that permit future comparisons.
Conclusions
ECLIM-SEHOP facilitates Spanish children and adolescents diagnosed with cancer and blood disorders to access state-of-the-art diagnostic and therapeutic strategies.
Collapse
|
31
|
Auge J, Hurtado H, Garcia A, Carot L, Grau J, Buron A, Pellise M, Hernández C, Tora I, Castells X, Macia F, Castells A, Bessa X. Cumulative levels of fecal hemoglobin for improving colorectal cancer screening management. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
González-López G, Descalzo-Gallego M, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-El Ahmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, García-Doval I, Buendía-Eisman A, Buendía A, Fernández-Crehuet P, Husein-ElAhmed H, Vega J, Viera A, Manuel Carrascosa J, Ferrán M, Gómez E, Ascanio L, García Doval I, Arias S, Gilaberte Y, Sánchez JA, Serrano A, Castillo R, Fernandez R, Armario J, Lluc Cantalejo C, Albarrán C, Cruz Martín M, Martín JA, Barabash R, Pérez L, Salamanca M, Hernández C, Millán JF, Ruiz I, Armesto S, González M, Beteta V, Cuadrado de Valles C, Cristóbal P, Roth MM, Garcias J, Fernandez de Misa R, García E, Rivero MDP, Suárez J, Farthmann B, Álvarez A, García I, Morales CE, Zemba MC, Repiso T, Sastre C, Ubals M, Fernández A, González U, Grimalt R, Gómez S, López I, Gemigniani FA, Izquierdo MJ, Alfageme F, Barrientos N, Pericet LM, Vidal S, Camarero C, Lázaro P, García C, de Pablo MP, Herranz P, del Olmo N, Castellanos M, Jiménez N, Aboín S, Aldanondo I, Juanes A, Arranz DM, González O, Casas L, Vázquez JJ, Peña C, Cubero JL, Feal C, Mayo ME, Iglesias N, Rojo R, Aniz E, Kindem S, Barrado N, Tirado M, Quecedo E, Hernández I, Sahuquillo A, Bella R, García R, Calle A, Messeguer F, Alfaro A, Casanova L, Aspe L, Moreno MP, Trébol I, Serrano G, Alcalde VM, García P, Coscojuela C. Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study. Actas Dermo-Sifiliográficas (English Edition) 2019. [DOI: 10.1016/j.adengl.2019.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
33
|
Miras I, Ramírez N, Sánchez P, Hernández C, Acosta D. Pneumoperitoneum by subcutaneous injections of GLP-1 analogues. A case report. ENDOCRINOL DIAB NUTR 2018; 65:548-549. [PMID: 30077633 DOI: 10.1016/j.endinu.2018.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Revised: 06/18/2018] [Accepted: 06/19/2018] [Indexed: 10/28/2022]
Affiliation(s)
- Isabel Miras
- Unidad de Gestión Clínica de Oncología Médica, Radioterapia y Radiofísica, Hospital Universitario Virgen del Rocío, Sevilla, España.
| | - Nieves Ramírez
- Unidad de Gestión Clínica de Medicina Integral, Hospital Universitario Virgen del Rocío, Sevilla, España
| | - Pablo Sánchez
- Unidad de Gestión Clínica de Oncología Médica, Radioterapia y Radiofísica, Hospital Universitario Virgen del Rocío, Sevilla, España
| | - Carlos Hernández
- Unidad de Gestión Clínica de Medicina Integral, Hospital Universitario Virgen del Rocío, Sevilla, España
| | - Domingo Acosta
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España
| |
Collapse
|
34
|
Hernández C, Ulloa J, Pizza S, Moreno M. Adenoma adrenocortical ectópico parahiliar renal, en paciente con síndrome de Cushing independiente de ACTH. Abordaje laparoscópico. Reporte de caso y revisión de la literatura. Urol Colomb 2018. [DOI: 10.1016/j.uroco.2017.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Objetivos El adenoma adrenocortical ectópico es el producto de la transformación de tejido adrenal ectópico embriológico en adenoma funcionante. Su asociación con síndrome de Cushing corresponde a menos del 2% de los casos. El presente es el noveno caso reportado en la literatura, por lo tanto se pretende recalcar la manera de realizar un adecuado abordaje diagnóstico multidisciplinario logrando el enfoque quirúrgico que permite el mejor tratamiento.
Materiales y métodos Búsqueda en bases de datos Pubmed, Lilacs, Embase. Revisión de la historia clínica y seguimiento postoperatorio.
Resultados Paciente femenina de 28 años quien presentó un aborto en primer trimestre de embarazo, asociado a hipertensión arterial, facies de luna llena y obesidad centrípeta. Se encuentra masa pararrenal izquierda. Se realiza abordaje laparoscópico para la resección de la misma, con patología que informa adenoma cortical adrenal. Resolución de sintomatología después del procedimiento.
Conclusiones Es un caso de baja frecuencia, donde es importante identificar la sintomatología temprana, así como realizar un abordaje multidisciplinario con el fin de realizar un correcto abordaje diagnóstico y terapéutico.
Collapse
Affiliation(s)
| | - José Ulloa
- Urólogo, Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Sara Pizza
- Médica y cirujana, Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Mauricio Moreno
- Urólogo, Unidad de Urología, Hospital de la Policía, Bogotá, Colombia
| |
Collapse
|
35
|
|
36
|
Hernández C, Paz-Zulueta M, Parás-Bravo P, Pellico A, Sarabia R, Santibáñez M. Impact of active video games on body mass index in children and adolescents: Systematic review and meta-analysis evaluating the quality of primary studies. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
37
|
Gisbert-Ferrándiz L, Salvador P, Ortiz-Masiá D, Macías-Ceja DC, Orden S, Esplugues JV, Calatayud S, Hinojosa J, Barrachina MD, Hernández C. A Single Nucleotide Polymorphism in the Vitamin D Receptor Gene Is Associated With Decreased Levels of the Protein and a Penetrating Pattern in Crohn's Disease. Inflamm Bowel Dis 2018; 24:1462-1470. [PMID: 29788141 DOI: 10.1093/ibd/izy094] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Indexed: 02/06/2023]
Abstract
BACKGROUND Vitamin D signaling modulates inflammation through the vitamin D receptor (VDR). The synonymous single nucleotide polymorphism (SNP) rs731236, located in the VDR gene, has been associated with a higher risk of Crohn's disease (CD). We analyzed differences in VDR expression levels among CD patients who were homozygous for allelic variants in this SNP and their relevance for disease course. METHODS DNA was extracted from blood samples of CD patients, and SNP genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism. Fresh blood from patients was used to isolate peripheral blood mononuclear cells (PBMCs) or to determine the expression of adhesion molecules by flow cytometry. We analyzed the gene expression of VDR and several cytokines in PBMCs using real-time polymerase chain reaction and the protein levels of VDR, NFκB, and IκBα by immunoblot. In addition, we collected complete clinical data for a group of 103 patients, including age at diagnosis, disease location, and disease behavior to compare patient characteristics with respect to genotype. RESULTS We found that CD patients who were homozygous for the risk allele presented lower levels of VDR protein in PBMCs, and that this was associated with an upregulation of IL1β mRNA and activation of lymphocytic adhesion molecules. These patients had a higher risk of developing a B3-penetrating phenotype and of needing to undergo surgery. CONCLUSION Our data highlight the relevance of vitamin D/VDR signaling in modulating the subjacent inflammation that leads to CD-related complications.
Collapse
Affiliation(s)
| | - Pedro Salvador
- Departamento de Farmacología and CIBERehd, Valencia, Spain
| | - Dolores Ortiz-Masiá
- Departamento de Medicina and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | | | | | - Juan Vicente Esplugues
- Departamento de Farmacología and CIBERehd, Valencia, Spain.,FISABIO, Hospital Dr. Peset, Valencia, Spain
| | - Sara Calatayud
- Departamento de Farmacología and CIBERehd, Valencia, Spain
| | - Joaquín Hinojosa
- Servicio de Gastroenterología, Hospital de Manises, Valencia, Spain
| | | | - Carlos Hernández
- Departamento de Farmacología and CIBERehd, Valencia, Spain.,FISABIO, Hospital Dr. Peset, Valencia, Spain
| |
Collapse
|
38
|
Rojo C, Jaime F, Azócar L, Hernández C, Villagrán A, Miquel JF, Arancibia G. Concordance between Lactose Quick Test, hydrogen-methane breath test and genotyping for the diagnosis of lactose malabsorption in children. Neurogastroenterol Motil 2018; 30:e13271. [PMID: 29266556 DOI: 10.1111/nmo.13271] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Accepted: 11/29/2017] [Indexed: 02/08/2023]
Abstract
BACKGROUND Lactose intolerance is a frequent condition in certain populations. Different methods for diagnosis exist. There is scarce literature regarding Lactose Quick Test (LQT) and concordance with other methods for lactose intolerance diagnosis in children. METHODS Prospectively, we included children who underwent gastroduodenoscopy for evaluation of abdominal pain. We obtained a duodenal sample for LQT and blood sample for genetic test to evaluate LCT C>T-13910 variant. Later, patients underwent breath test with lactose, to evaluate malabsorption. We evaluated the concordance between the three different tests. KEY RESULTS We included 46 patients, 56.5% women. Mean age was 13.2 years (range 9-18 years). 66.6% of patients had lactose malabsorption according to breath test; 64.4% were homozygous CC; and 91.3% had hypolactasia (mild or severe) according to LQT. None of the patients with normolactasia had altered breath test. Genetic test had a substantial agreement (k = 0.675) with breath test and fair agreement (k = 0.301) with LQT. LQT had fair agreement (k = 0.348) with breath test. CONCLUSIONS & INFERENCES Genetic test had better concordance with breath test than LQT to diagnose lactose malabsorption, however, none of the patients with normal LQT had lactose malabsorption. In patients who undergo gastroduodenoscopy to study abdominal pain, it seems reasonable to perform LQT, and, in those with hypolactasia, to perform breath test.
Collapse
Affiliation(s)
- C Rojo
- Faculty of Medicine, Division of Pediatrics, Department of Pediatric Gastroenterology and Nutrition, Pontificia Universidad Católica de Chile, Santiago, Chile.,Hospital Regional Leonardo Guzmán, Antofagasta, Chile
| | - F Jaime
- Faculty of Medicine, Division of Pediatrics, Department of Pediatric Gastroenterology and Nutrition, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - L Azócar
- Faculty of Medicine, Departament of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C Hernández
- Faculty of Medicine, Division of Pediatrics, Department of Pediatric Gastroenterology and Nutrition, Laboratory of Gastrointestinal Infections and Immunology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - A Villagrán
- Faculty of Medicine, Division of Pediatrics, Department of Pediatric Gastroenterology and Nutrition, Laboratory of Gastrointestinal Infections and Immunology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - J F Miquel
- Faculty of Medicine, Departament of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - G Arancibia
- Faculty of Medicine, Division of Pediatrics, Department of Pediatric Gastroenterology and Nutrition, Pontificia Universidad Católica de Chile, Santiago, Chile
| |
Collapse
|
39
|
Salvador P, Macías-Ceja DC, Gisbert-Ferrándiz L, Hernández C, Bernardo D, Alós R, Navarro-Vicente F, Esplugues JV, Ortiz-Masiá D, Barrachina MD, Calatayud S. CD16+ Macrophages Mediate Fibrosis in Inflammatory Bowel Disease. J Crohns Colitis 2018; 12:589-599. [PMID: 29304229 DOI: 10.1093/ecco-jcc/jjx185] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2017] [Accepted: 12/29/2017] [Indexed: 12/24/2022]
Abstract
BACKGROUND AND AIMS Fibrosis is a common complication of Crohn's disease [CD], and is related to dysregulated tissular repair following inflammation, in which macrophages play a central role. We have previously observed that STAT6-/- mice present delayed mucosal recovery after 2,4,6-trinitrobenzenesulfonic acid [TNBS]-induced colitis due to a deficiency in reparatory interleukin-4 [IL4]/STAT6-dependent M2 macrophages, which can be reverted by the exogenous transfer of this cell type. In the present study, we analyse the role of STAT6-dependent macrophages in intestinal fibrosis. METHODS Colitis was induced by weekly intra-rectal administration of TNBS [6 weeks] to STAT6-/- mice and wild-type [WT] animals. Colonic surgical resections were obtained from CD patients and from colon cancer patients. RESULTS Chronic colitis provoked a fibrogenic response in STAT6-/- mice, but not in WT animals. An accumulation of M2 macrophages, defined as CD206+ cells, was observed in WT mice, but not in STAT6-/- animals. Instead, the latter group showed an increase in CD16+ macrophages that correlated with the expression of fibrogenic markers. CD16+ macrophages were also increased in the damaged mucosa of Crohn's disease patients with stenotic or penetrating complications. Finally, administration of IL4-treated WT macrophages to STAT6-/- mice reduced TNBS-induced fibrosis. CONCLUSIONS Our study demonstrates that STAT6 deficiency dysregulates the macrophage response to inflammatory outbursts by increasing the presence of a population of CD16+ macrophages that seems to contribute to intestinal fibrosis.
Collapse
Affiliation(s)
- Pedro Salvador
- Departamento de Farmacología and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | | | - Laura Gisbert-Ferrándiz
- Departamento de Farmacología and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | | | - David Bernardo
- Unidad de Gastroenterología, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain
| | - Rafael Alós
- Servicio de Cirugía, Hospital de Sagunto, Sagunto, Valencia, Spain
| | | | - Juan Vicente Esplugues
- Departamento de Farmacología and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Dolores Ortiz-Masiá
- Departamento de Medicina and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Maria Dolores Barrachina
- Departamento de Farmacología and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Sara Calatayud
- Departamento de Farmacología and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| |
Collapse
|
40
|
Sánchez E, Lecube A, Betriu À, Hernández C, López-Cano C, Gutiérrez-Carrasquilla L, Kerkeni M, Yeramian A, Purroy F, Pamplona R, Farràs C, Fernández E, Barbé F, Simó R, Hernández M, Rius F, Polanco D, de la Torre MS, Torres G, Godoy P, Portero-Otin M, Jové M, Colàs-Compàs L, Benabdelhak I, Miquel E, Ortega M, Valdivielso JM, Bermúdez M, Martínez-Alonso M. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project. Diabetes Metab 2018; 45:595-598. [PMID: 29706471 DOI: 10.1016/j.diabet.2018.04.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 04/04/2018] [Accepted: 04/10/2018] [Indexed: 12/17/2022]
Affiliation(s)
- E Sánchez
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain
| | - A Lecube
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
| | - À Betriu
- Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Spain
| | - C Hernández
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Endocrinology and Nutrition Department, University Hospital Vall d'Hebron, Diabetes and Metabolism Research Unit, VHIR, Autonomous University of Barcelona, Barcelona, Spain
| | - C López-Cano
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain
| | - L Gutiérrez-Carrasquilla
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain
| | - M Kerkeni
- Higher Institute of Biotechnology, Laboratory of Biochemistry, Faculty of Medicine, University of Monastir, Monastir, Tunisia
| | - A Yeramian
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain
| | - F Purroy
- Stroke Unit, University Hospital Arnau de Vilanova, Clinical Neurosciences Group, IRBLleida, University of Lleida, Lleida, Spain
| | - R Pamplona
- Metabolic Pathophysiology Group, IRBLleida, University of Lleida, Lleida, Spain
| | - C Farràs
- Borges Blanques Primary Health Care Unit, Borges Blanques, Lleida, Spain
| | - E Fernández
- Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Spain
| | - F Barbé
- Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, University Hospital Arnau de Vilanova, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - R Simó
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Endocrinology and Nutrition Department, University Hospital Vall d'Hebron, Diabetes and Metabolism Research Unit, VHIR, Autonomous University of Barcelona, Barcelona, Spain.
| | | | - M Hernández
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - F Rius
- Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism research group (ODIM), IRBLleida, University of Lleida, Lleida, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - D Polanco
- Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, University Hospital Arnau de Vilanova, Lleida, Spain
| | - M S de la Torre
- Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, University Hospital Arnau de Vilanova, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - G Torres
- Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, University Hospital Arnau de Vilanova, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - P Godoy
- Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, University Hospital Arnau de Vilanova, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - M Portero-Otin
- Metabolic Pathophysiology Group, IRBLleida, University of Lleida, Lleida, Spain
| | - M Jové
- Metabolic Pathophysiology Group, IRBLleida, University of Lleida, Lleida, Spain
| | - L Colàs-Compàs
- Stroke Unit, University Hospital Arnau de Vilanova, Clinical Neurosciences Group, IRBLleida, University of Lleida, Lleida, Spain
| | - I Benabdelhak
- Stroke Unit, University Hospital Arnau de Vilanova, Clinical Neurosciences Group, IRBLleida, University of Lleida, Lleida, Spain
| | - E Miquel
- Borges Blanques Primary Health Care Unit, Borges Blanques, Lleida, Spain
| | - M Ortega
- Borges Blanques Primary Health Care Unit, Borges Blanques, Lleida, Spain
| | - J M Valdivielso
- Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Spain
| | - M Bermúdez
- Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Spain
| | - M Martínez-Alonso
- Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Spain
| |
Collapse
|
41
|
Rodriguez-Lopez M, Arrivillaga M, Holguín J, León H, Ávila A, Hernández C, Rincón-Hoyos HG. [Profiles of high-frequency users of primary care services and associations with depressive anxiety disorders in Cali, Colombia]. ACTA ACUST UNITED AC 2018; 33:478-488. [PMID: 27831611 DOI: 10.17843/rpmesp.2016.333.2335] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Accepted: 05/04/2016] [Indexed: 11/06/2022]
Abstract
Objectives. To determine the profiles of highly frequent users of primary care services and the associations of these profiles with depressive anxiety disorders in Cali, Colombia. Materials and Methods. A case-control study, high-frequency cases were defined as those involving patients with a percentile >75 with regard to the frequency of spontaneous use of outpatient facilities in the last 12 months; controls were defined as those with a percentile <25. A multiple correspondence analysis was used to describe patient profiles, and the influences of depression and anxiety on frequent attendance was determined via logistic regression. Results. Among the 780 participating patients, differences in the profiles among frequent users and controls were related to predisposing factors such as sex, age, and education, capacity factors such as the time required to visit the institution and the means of transport used, and need factors such as health perceptions, social support, family function, and the presence of anxiety or depressive disorders. A depression or anxiety disorder was found to associate positively with frequent attendance (adjusted odds ratio [aOR]: 1.99, 95% confidence interval [CI]: 1.19-3.31) and a referral system (aOR: 1.61, 95% CI: 1.01-2.76), but negatively with mild or no family dysfunction (aOR: 0.79; 95% CI: 0.48-0.88) after adjusting for age, sex, ethnicity, and health service-providing institutions. Conclusions. The profiles of high-frequency patients differ from control patients with respect to factors related to capacity, need, and willingness; in particular, the latter were independently associated with frequent attendance. Notably, the presence of an anxious or depressive disorder doubled the risk of highfrequency attendance at a primary care facility.
Collapse
Affiliation(s)
- Mérida Rodriguez-Lopez
- Grupo de investigación de Salud y Calidad de Vida de la Pontificia Universidad Javeriana. Cali, Colombia.,Grupo de evaluación de servicios de salud de la Caja de Compensación Familiar del Valle del Cauca. Cali, Colombia
| | - Marcela Arrivillaga
- Departamento de Salud Pública y Epidemiología de la Pontificia Universidad Javeriana. Cali, Colombia
| | - Jorge Holguín
- Departamento de Salud Pública y Epidemiología de la Pontificia Universidad Javeriana. Cali, Colombia
| | | | | | - Carlos Hernández
- Grupo de evaluación de servicios de salud de la Caja de Compensación Familiar del Valle del Cauca. Cali, Colombia.,Grupo de investigación servicios de salud de la Universidad del Valle. Cali, Colombia
| | | |
Collapse
|
42
|
Jaime F, Villagrán A, Hernández C, Ortiz M, Serrano C, Harris PR. Functional gastrointestinal disorders in children from low socio-economic status and Helicobacter pylori infection. Child Care Health Dev 2018; 44:319-325. [PMID: 28707297 DOI: 10.1111/cch.12486] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Accepted: 06/17/2017] [Indexed: 02/06/2023]
Abstract
BACKGROUND Most studies on functional gastrointestinal disorders (FGIDs) in children are based on data from the northern hemisphere. Scientific reports are arising in South American population, but little is still known about children from low socio-economic status (SES), where Helicobacter pylori infection is endemic. Our objective was to evaluate the prevalence of FGIDs in school children from low SES and its relationship with H. pylori infection. METHODS Children from 3 public schools of low SES from Santiago de Chile were included. Students completed the Rome III Questionnaire and a survey about other symptoms. Also, the 13 C urea breath test determined the presence of H. pylori infection. RESULTS Five hundred six children were included, where 48% were male, with a median age of 15.7 years (range 7.1-19.6). Forty-two percent had some FGID, aerophagia and functional constipation being the most frequent. Females (adjusted OR 1.5, 95% CI [1.1, 2.2]), those children with parents within the lowest level of education (adjusted OR 1.6, 95% CI: 1.1-2.4), and family history of gastric cancer (adjusted OR 1.9, 95% CI: 1.2-3.1) were related to FGIDs. The prevalence of H. pylori infection was 55.9% (95% CI [50.7, 60.9]). In multivariable analysis, the presence of abdominal pain (OR 1.55, 95% CI [1.02, 2.36]), but not FGIDs, was related to H. pylori infection. CONCLUSIONS FGIDs are common in low SES students. A low educational level of the household head, family history of gastric cancer. and being female are related to the development of FGIDs. In this study, no relationship between the presence of H. pylori and FGIDs was found.
Collapse
Affiliation(s)
- F Jaime
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - A Villagrán
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C Hernández
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - M Ortiz
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C Serrano
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - P R Harris
- Department of Pediatric Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| |
Collapse
|
43
|
Noya BAD, Pérez-Chacón G, Díaz-Bello Z, Dickson S, Muñoz-Calderón A, Hernández C, Pérez Y, Mauriello L, Moronta E. Description of an oral Chagas disease outbreak in Venezuela, including a vertically transmitted case. Mem Inst Oswaldo Cruz 2017; 112:569-571. [PMID: 28767982 PMCID: PMC5530549 DOI: 10.1590/0074-02760170009] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2017] [Accepted: 03/24/2017] [Indexed: 11/22/2022] Open
Abstract
We describe the eleventh major outbreak of foodborne Trypanosoma cruzi transmission in urban Venezuela, including evidence for vertical transmission from the index case to her fetus. After confirming fetal death at 24 weeks of gestation, pregnancy interruption was performed. On direct examination of the amniotic fluid, trypomastigotes were detected. T. cruzi specific-polymerase chain reaction (PCR) also proved positive when examining autopsied fetal organs. Finally, microscopic fetal heart examination revealed amastigote nests. Acute orally transmitted Chagas disease can be life threatening or even fatal for pregnant women and unborn fetuses owing to vertical transmission. There is therefore an urgent need to improve national epidemiologic control measures.
Collapse
Affiliation(s)
- Belkisyolé Alarcón de Noya
- Universidad Central de Venezuela, Facultad de Medicina, Instituto de Medicina Tropical, Sección de Inmunología, Caracas, Venezuela
| | - Gladymar Pérez-Chacón
- Universidad Central de Venezuela, Facultad de Medicina, Escuela de Medicina José María Vargas, Parasitología, Caracas, Venezuela
| | - Zoraida Díaz-Bello
- Universidad Central de Venezuela, Facultad de Medicina, Instituto de Medicina Tropical, Sección de Inmunología, Caracas, Venezuela
| | - Sonia Dickson
- Hospital de Clínicas Caracas, Departamento de Anatomía Patológica, Caracas, Venezuela
| | - Arturo Muñoz-Calderón
- Universidad Central de Venezuela, Facultad de Medicina, Instituto de Medicina Tropical, Sección de Inmunología, Caracas, Venezuela
| | - Carlos Hernández
- Hospital de Clínicas Caracas, Departamento de Obstetricia y Ginecología, Caracas, Venezuela
| | | | - Luciano Mauriello
- Universidad Central de Venezuela, Facultad de Medicina, Instituto de Medicina Tropical, Sección de Inmunología, Caracas, Venezuela
| | - Eyleen Moronta
- Universidad Central de Venezuela, Facultad de Medicina, Instituto de Medicina Tropical, Sección de Inmunología, Caracas, Venezuela
| |
Collapse
|
44
|
Hernández C, Simó-Servat A, Bogdanov P, Simó R. Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms. J Endocrinol Invest 2017; 40:925-935. [PMID: 28357783 DOI: 10.1007/s40618-017-0648-4] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Accepted: 02/23/2017] [Indexed: 12/22/2022]
Abstract
Diabetic retinopathy (DR) is the leading cause of visual impairment and preventable blindness and represents a significant socioeconomic cost for healthcare systems worldwide. In early stages of DR the only therapeutic strategy that physicians can offer is a tight control of the risk factors for DR (mainly blood glucose and blood pressure). The currently available treatments for DR are applicable only at advanced stages of the disease and are associated with significant adverse effects. Therefore, new treatments for the early stages of DR are needed. However, in early stages of DR invasive treatments such as intravitreal injections are too aggressive, and topical treatment seems to be an emerging route. In the present review, therapeutic strategies based on the main pathogenic mechanisms involved in the development of DR are reviewed. The main gap in the clinical setting is the treatment of early stages of DR and, therefore, this review emphasizes in this issue by giving an overview of potential druggable targets. By understanding of disease-specific pathogenic mechanisms, biological heterogeneity and progression patterns in early and advanced DR a more personalised approach to patient treatment will be implemented.
Collapse
Affiliation(s)
- C Hernández
- CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain
| | - A Simó-Servat
- Servicio de Endocrinología y Nutrición, Hospital Universitario de Bellvitge, Universitat de Barcelona, L'Hospitalet del LLobregat, Barcelona, Spain
| | - P Bogdanov
- CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain
| | - R Simó
- CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas) and Diabetes and Metabolism Research Unit, Vall Hebron Institut de Recerca (VHIR), Universitat Autónoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.
| |
Collapse
|
45
|
Gómez-Veiga F, Rodríguez-Antolín A, Miñana B, Hernández C, Suárez J, Fernández-Gómez J, Unda M, Burgos J, Alcaraz A, Rodríguez P, Medina R, Castiñeiras J, Moreno C, Pedrosa E, Cózar J. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study - GESCAP group. Actas Urol Esp 2017; 41:359-367. [PMID: 28285790 DOI: 10.1016/j.acuro.2016.10.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Revised: 10/11/2016] [Accepted: 10/13/2016] [Indexed: 10/20/2022]
Abstract
OBJECTIVE To assess the adherence to European Association of Urology (EAU) guidelines in the management of prostate cancer (PCa) in Spain. PATIENTS AND METHODS Epidemiological, population-based, study including a national representative sample of 3,918 incident patients with histopathological confirmation during 2010; 95% of the patient's sample was followed up for at least one year. Diagnosis along with treatment related variables (for localized PCa -low, intermediate, high and locally-advanced by D'Amico risk stratification) was recorded. Differences between groups were tested with Chi-squared and Kruskal-Wallis tests. RESULTS Mean (SD) age of PCa patients was 68.48 (8.18). Regarding diagnostic by biopsy procedures, 64.56% of all patients had 8-12 cores in first biopsy and 46.5% of the patients over 75 years, with PSA<10ng/mL were biopsied. Staging by Computer Tomography (CT) or Bone Scan (BS) was used for determining tumor extension in 60.09% of high-risk cases and was applied differentially depending on patients' age; 3,293 (84.05%) patients received a treatment for localized PCa. Radical prostatectomy was done in 1,277 patients and 206 out of these patients also had a lymphadenectomy, being 4.64% low-risk, 22.81% intermediate-risk and 36.00% high-risk patients; 86.08% of 1,082 patients who had radiotherapy were treated with 3D or IMRT and 35.77% received a dose ≥75Gy; 419 patients were treated with brachytherapy (BT): 54.81% were low-risk patients, 22.84% intermediate-risk and 12.98% high-risk. Hormonotherapy (HT, n=521) was applied as single therapy in 9.46% of low-risk and 17.92% of intermediate-risk patients. Additionally, HT was combined with RT in 14.34% of lower-risk patients and 58.26% of high-risk patients, and 67.19% low-intermediate risk with RT and/or BT received neoadjuvant/concomitant/adjuvant HT. Finally, 83.75% of high-risk patients undergoing RT and/or BT also received HT. CONCLUSIONS Although EAU guidelines for PCa management are easily available in Europe, the adherence to their recommendations is low, finding the highest discrepancies in the need for a prostate biopsy and the diagnostic methods. Improve information and educational programs could allow a higher adherence to the guidelines and reduce the variability in daily practice. (Controlled-trials.com: ISRCTN19893319).
Collapse
|
46
|
Macias-Ceja DC, Cosín-Roger J, Ortiz-Masiá D, Salvador P, Hernández C, Esplugues JV, Calatayud S, Barrachina MD. Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis. Br J Pharmacol 2017; 174:2501-2511. [PMID: 28500644 DOI: 10.1111/bph.13860] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 05/02/2017] [Accepted: 05/03/2017] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND AND PURPOSE Defective autophagy contributes to the pathogenesis of inflammatory disorders such as inflammatory bowel disease and there are interactions between autophagy and inflammation. Here we have analysed the effects of autophagy stimulators on murine colitis. EXPERIMENTAL APPROACH Mice were treated with intrarectal administration of 2,4,6-trinitrobenzenesulfonic acid (TNBS) (3.5 mg·20 g-1 ) and body weight was measured daily. Histological damage was scored 2 or 4 days after treatment. Some mice received trehalose (3% in drinking water 3 weeks before TNBS administration) or a daily administration of rapamycin (1.25 mg·kg-1 , i.p.), betanin (1 g·kg-1 , i.p.) or betanin + 3-methyladenine (3MA) (10 mg·kg-1 , i.p.). Protein levels of p-mTOR, p62, LC3, BCL10, NFκB, IκBα and p-IκBα in mucosa were determined by Western blots and mRNA expression of TNFα, IL1β, IL6, IL10, COX2, CCR7, CD11c, inducible NOS and CD86 by qRT-PCR. KEY RESULTS Impaired autophagy associated with body weight loss and intestinal damage was detected in the mucosa of TNBS-treated mice. Administration of trehalose, rapamycin or betanin prevented the impaired autophagic flux induced by TNBS and decreased mucosal protein levels of BCL10, p-IκBα and NFκB-p65 and the expression of pro-inflammatory cytokines and M1 macrophage markers. Blockade of autophagosome formation by treatment with 3MA, prevented the reduction in protein levels of p62, BCL10, p-IκBα and NFκB-p65 induced by betanin in TNBS-treated mice and weakened the protective effects of betanin on murine colitis. CONCLUSIONS AND IMPLICATIONS Pharmacological stimulation of mucosal autophagy reduced intestinal inflammation and improved murine colitis.
Collapse
Affiliation(s)
| | - Jesús Cosín-Roger
- Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Dolores Ortiz-Masiá
- Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.,Departamento de Medicina, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Pedro Salvador
- Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Carlos Hernández
- FISABIO, Hospital Dr. Peset, Valencia, Spain.,Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Juan V Esplugues
- FISABIO, Hospital Dr. Peset, Valencia, Spain.,Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - Sara Calatayud
- Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| | - María D Barrachina
- Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain
| |
Collapse
|
47
|
Verdugo C, Jiménez O, Hernández C, Álvarez P, Espinoza A, González-Acuña D. Infection with Borrelia chilensis in Ixodes stilesi ticks collected from Pudu puda deer. Ticks Tick Borne Dis 2017; 8:733-740. [PMID: 28549720 DOI: 10.1016/j.ttbdis.2017.05.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2017] [Revised: 05/15/2017] [Accepted: 05/16/2017] [Indexed: 11/29/2022]
Abstract
Lyme borreliosis is a vector-borne zoonosis caused by Borrelia burgdorferi sensu lato species complex spirochetes, which are maintained in transmission cycles among vertebrates and Ixodes ticks. Recently, a new genospecies within this complex, Borrelia chilensis, was described in Ixodes stilesi collected from the environment and from rodents in Chile. This tick also infests the native Southern pudu deer (Pudu puda). The objectives of this study were to investigate the prevalence, intensity of infestation, and aggregation of hard ticks on this deer species, and to determine the presence of borrelial pathogens in the ticks. Sixty-six deer were examined over a two-year period. A total of 179 ticks of two species, I. stilesi and Ixodes taglei, were collected. Of those, 100 were adults, 78 were nymphs, and one was a larva. Ixodes stilesi was the most prevalent tick (47%) and was highly aggregated (D=0.77) on the deer. Deer body weight was positively associated with tick burden. Borrelia spirochetes were detected in two (6.45%) of the examined I. stilesi ticks. Phylogenetic analyses of 16S and flaB gene sequences positioned these samples in the same clade with Borrelia chilensis VA1 previously described from Chile. These findings suggest that I. stilesi may play a role in the local persistence of B. chilensis. Further studies are required to fully understand the mechanisms of natural transmission of B. chilensis and the risk of infection in humans.
Collapse
Affiliation(s)
- Claudio Verdugo
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile; Programa de Investigación Aplicada en Fauna Silvestre, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile.
| | - Omar Jiménez
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile
| | - Carlos Hernández
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile
| | - Pedro Álvarez
- Instituto de Patología Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile
| | - Angelo Espinoza
- Programa de Investigación Aplicada en Fauna Silvestre, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile; Centro de Rehabilitación de Fauna Silvestre, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Av. Los Laureles s/n, Valdivia, Chile
| | - Daniel González-Acuña
- Departamento de Ciencia Animal, Facultad de Ciencias Veterinarias, Universidad de Concepción, Av. Vicente Méndez 595, Chillán, Chile
| |
Collapse
|
48
|
Casanello P, Hernández C, Carrasco-Wong I, Muñoz-Muñoz E, Jaramillo A, Soto G, Carrasco K, Castro-Rodríguez J, Uauy R, Krause B. Intrauterine growth trajectories modify the epigenetic programming of vascular-related genes in human umbilical artery endothelium and cord adiponectin levels. Placenta 2017. [DOI: 10.1016/j.placenta.2017.01.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Hernández C, González D. Study of the Start-Up Ecosystem in Lima, Peru: Analysis of Interorganizational Networks. Journal of Technology Management & Innovation 2017. [DOI: 10.4067/s0718-27242017000100008] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
50
|
Lecube A, Romero O, Sampol G, Mestre O, Ciudin A, Sánchez E, Hernández C, Caixàs A, Vigil L, Simó R. Sleep biosignature of Type 2 diabetes: a case-control study. Diabet Med 2017; 34:79-85. [PMID: 27278263 DOI: 10.1111/dme.13161] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/07/2016] [Indexed: 01/30/2023]
Abstract
AIM To determine whether or not the sleep disturbances associated with Type 2 diabetes affect the structure of sleep. METHODS We designed a case-control study in 76 patients with Type 2 diabetes and 76 control subjects without Type 2 diabetes, matched by age, gender, BMI and waist and neck circumferences. A subgroup of 32 patients with Type 2 diabetes was also matched with 64 control subjects without Type 2 diabetes according to apnoea-hypopnoea index score. Examination included an overnight full polysomnography. RESULTS No differences in the percentage of time spent in either rapid eye movement or non-rapid eye movement sleep were observed between groups; however, patients with Type 2 diabetes had more microarousal events during sleep than control subjects [41.4 (total range 4.0-104.4) vs 20.7 (total range 1.3-94.5) events/h; P < 0.001]. These differences were mainly observed during the non-rapid eye movement sleep [7.4 (total range 0-107.2) vs 0.2 (total range 0-65.2) events/h; P < 0.001]. In addition, sleep variables related to oxygen saturation measures, such as the percentage of time spent with oxygen saturation ≤90%, were significantly greater during the rapid eye movement sleep in patients with Type 2 diabetes [20.3 (total range 0-99.2) vs. 10.5 (total range 0-94.0)%; P = 0.047]. This pattern was maintained in the subgroup of patients matched by apnoea-hypopnaea index. Finally, stepwise regression analyses showed that apnoea-hypopnoea index, the presence of Type 2 diabetes and fasting plasma glucose value were independently associated with the number of microarousals (R2 =0.667). CONCLUSIONS Type 2 diabetes is associated with an altered sleep structure, with different effects according to rapid eye movement (increase in nocturnal hypoxia) or non-rapid eye movement (increase in sleep fragmentation) sleep.
Collapse
Affiliation(s)
- A Lecube
- Department of Endocrinology and Nutrition, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, Universitat de Lleida, Lleida, Spain
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Department of Endocrinology, Diabetes and Metabolism Research Unit, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - O Romero
- CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Sleep Unit, Department of Neurophysiology, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - G Sampol
- CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Sleep Unit, Department of Pneumology, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - O Mestre
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Department of Endocrinology, Diabetes and Metabolism Research Unit, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - A Ciudin
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Department of Endocrinology, Diabetes and Metabolism Research Unit, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - E Sánchez
- Department of Endocrinology and Nutrition, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, Universitat de Lleida, Lleida, Spain
| | - C Hernández
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Department of Endocrinology, Diabetes and Metabolism Research Unit, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - A Caixàs
- Department of Endocrinology and Nutrition, Corporació Sanitària Parc Taulí, Parc Taulí, Spain
| | - L Vigil
- Sleep Unit, Department of Pneumology, Corporació Sanitària Parc Taulí, Sabadell, Spain
| | - R Simó
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Department of Endocrinology, Diabetes and Metabolism Research Unit, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|